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Schistosoma haematobium ova exiting the tissue through the cervical mucosal membrane. 
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Definitions and abbreviations 
Capillary bud CD31 immunostained endothelial cell structure without 
a visible lumen or peri-endothelial structures 
CCR5 Chemokine receptor, also a co-receptor for HIV 
CD Cluster of differentiation 
CD31 Immunohistochemical marker of endothelial cells 
CD3 Immunohistochemical marker of T cells  
CD4 Immunohistochemical marker of CD4+ T cells, and 
main receptor for HIV 
CD68 Immunohistochemical marker of monocyte-derived cell; 
monocytes and macrophages 
CD8 Immunohistochemical marker of CD8+ T cells 
CD4+ T lymphocyte / cell T cell expressing CD4 receptor on the surface 
Computer-assisted image analysis Digital quantification of image components 
Contact bleeding Mucosal bleeding by only slight contact 
CXCR4 Chemokine receptor, also a co-receptor for HIV 
Cytotoxic T cell CD8+ T cell with the capacity to destroy human cells 
infested with intracellular pathogens 
Delayed hypersensitivity (type IV) A type of T cell-mediated immune response 
Dendritic cell (DC) A “guardian” cell of the innate immune system 
Ectocervix The vaginal portion of the uterine cervix 
Endocervix The canal connecting the vagina with the uterine cavity 
Endothelial cell Cell that lines the inner surface of a blood vessel 
Eosinophil granulocyte One of the main effector cells in the immune response to 
schistosomiasis 
Established blood vessel vWF-immunostained vessel structures other than buds 
Female genital schistosomiasis Schistosome ova in female genital tissue 
Female genital tract Ovaries, tubes, uterus including the cervix, and vagina 
Granulation tissue Tissue reaction with capillary buds, activated endothelial 
cells and immature fibroblasts 
Granuloma Histopathological reaction to a foreign body such as ova; 
clusters of immune cells, especially activated monocytes 
HE Haematoxylin and eosin; standard stain for microscopic 
examination of human tissue 
Histopathology The scientific study of tissue by light microscopy 
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HIV Human immunodeficiency virus 
HIV target cells The (CD4+) cells susceptible to HIV infection 
HIV transmission The transfer of HIV infection between individuals 
HPF High-power field; the microscopic area viewed through 
objective lens 40 
HPV Human papillomavirus 
IL Interleukin 
Immunohistochemistry Protein detection by use of immunological markers for 
analysis of cells and tissue structures 
Langerhans cell Dendritic cell in the mucosal membrane and skin 
Macrophage Monocyte-derived phagocytic cell (literally big eater) 
Morphological Here with regard to histopathological findings 
Mucosa The epithelial lining of inner surfaces, such as the 
alimentary, urinary and genital tracts 
Ovum (ova) Egg(s); here parasite egg(s), which may be viable or 
non-viable / calcified 
Plasma cell Mature B cell capable of producing antibodies 
Pseudotubercle Term previously used for granuloma (see this term) 
SEA Soluble egg antigen 
S100 (protein) Immunohistochemical marker of several cell types, 
among others dendritic cells 
Sandy patch Sandy looking mucosal area with or without distinct 
grains; a typical sign of S. haematobium infection 
Schistosoma haematobium Parasite that commonly infects the female genitals 
Rubbery nodule Pustoloid, firm and beige nodule in the mucosa, 
associated with S. haematobium infection 
Schistosomiasis Disease caused by infection with schistosomes 
T lymphocyte / cell Pivotal immune cell of the innate immune system 
Th1 / Th2 cell Subsets of CD4+ T lymphocytes 
Transformation zone The transitional zone between the squamous and 
columnar epithelium of the cervical portio; the main area 
of colposcopic examination with regards to cancer  
Urogenital Which affects the urinary and/or genital tract(s) 
vWF von Willebrand Factor; immunohistochemical marker of 
established blood vessels 
WHO World Health Organization 
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1.0. Summary 
Schistosomiasis is, after malaria, the most important parasite disease in terms of public 
health impact. Schistosoma haematobium infects millions of people through fresh water 
contact, especially in sub-Saharan Africa. Recent knowledge of the genital manifestations of 
schistosomiasis and the possible association with human immunodeficiency virus (HIV) 
infection, has led to increased focus on this common but neglected tropical disease. Anti-
schistosomal treatment could potentially become an intervention point against HIV 
transmission. It is therefore imperative that the possible mechanisms by which female 
genital S. haematobium infection might influence HIV transmission is explored. 
 
S. haematobium infection is a frequent cause of mucosal pathology in the female genital 
tract. To our knowledge, this is the first study to perform systematic immunohistochemical 
analyses on S. haematobium infected female genital mucosa. This thesis presents the results 
of up-to-date immunohistochemical and image analyses of periovular mucosal blood vessels 
and HIV target cells, and of clinicopathological correlates in women with cervicovaginal S. 
haematobium infection in two cross-sectional studies in Malawi and Madagascar. 
 
In line with previous reports, we found a variety of tissue reactions to S. haematobium ova. 
Female genital mucosa infected with S. haematobium contained a higher density of HIV 
target cells, i.e. CD4+ T lymphocytes and CD68+ macrophages than uninfected mucosa. 
The infected genital mucosa was significantly more vascularised compared to healthy tissue. 
Clinicopathological analyses suggest that characteristic, abnormal mucosal blood vessels 
might be suggestive of a persistent tissue reaction to female genital S. haematobium ova, 
and that thrombosis might contribute to the pathogenesis. Finally, we developed a simple 
model for precise and efficient computer-assisted image analysis of immunostained tissue. 
 
In conclusion, the findings show that S. haematobium infected female genital mucosa may 
contain a higher density of HIV target cells and blood vessels than uninfected mucosa. 
Pathological changes in both acute and chronic tissue reactions to genital mucosal S. 
haematobium infection could facilitate cervicovaginal HIV transmission in women. Further 
studies are needed to explore the findings, and to provide clinical advice on the risks and 
effect of anti-schistosomal treatment on female genital schistosomiasis. 
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2.0. Background 
2.1. Schistosomiasis 
2.1.1. History 
The symptoms of schistosomiasis had been known for centuries when Schistosoma 
haematobium was first discovered by the German physician Bilharz in Egypt in 1851 [1]. 
Symptoms and signs of schistosomiasis have been found in Egyptian papyrus fragments as 
early as 1900 BC [2]. These descriptions have later been confirmed by the detection of S. 
haematobium ova in the kidneys of Egyptian mummies [3], and more recently of S. mansoni 
and S. japonicum in Egyptian and Chinese mummies, respectively [4,5]. 
 
In the beginning of the 20th century, S. mansoni and S. japonicum were distinguished from 
S. haematobium [6,7], followed by identification of the intermediate hosts; the fresh water 
snails, and thus the parasites’ life cycles [8]. The parasite and disease were named Bilharzia 
and bilharziasis, respectively, until 1954, when the international nomenclature was changed 
to Schistosoma and schistosomiasis [2]. However, both terms are still commonly used. 
 
2.1.2. Epidemiology 
Schistosomiasis is, next to malaria, the second most important cause of parasitic disease 
burden in terms of public health impact [9,10]. Close to 800 million people are currently 
exposed to schistosomiasis, and more than 600 million of these live in Africa [9,11]. 
Estimates indicate that more than 200 million Africans are infected; however, probably less 
than 15% of these are treated for the disease [12]. 
 
Five main schistosome species may cause disease in humans: S. haematobium, S. mansoni, 
S. japonicum, S. intercalatum and S. mekongi [13-16]. The geographical distribution of the 
various schistosome species follows the distribution of the respective intermediate hosts (see 
2.1.3. Life cycle) [17,18]. S. haematobium is found in Africa and the middle East, S. 
mansoni in Africa, the Caribbean, South America and the middle East, and S. japonicum in 
China, Indonesia and the Philippines (Figure 1) [17]. S. intercalatum and S. mekongi are 
found in limited areas of sub-Saharan Africa and Southeast Asia, respectively [17]. Man-
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made ecological changes such as irrigation and the migration of infected populations further 
contribute to the epidemiology of schistosomiasis [18,19]. 
 
 
Figure 1. The global distribution of schistosomiasis. (Reprinted with permission from 
Elsevier and courtesy of Professor B. Gryseels). 
 
2.1.3. Life cycle 
The main features of the life cycle are similar for the various schistosome species that cause 
disease in humans (Figure 2). Infection may be initiated when people through leisure or 
occupational activities, or otherwise come in skin contact with fresh water infested with 
schistosomal cercariae; the infectious larval stage of the parasite [13]. In case of infection, 
the cercariae penetrate the skin, develop into schistosomula, gain access to the blood stream 
and end up in the portal vein of the liver. Following sexual maturation, the pair of female 
and male schistosomes migrates against the blood stream to the site of ova deposition. 
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The female S. haematobium and S. intercalatum worms lay oval ova with a terminal spine, S. 
mansoni produce ova with a lateral spine, and S. japonicum and S. mekongi lay round ova 
with only a minute spine. For reasons still unknown, each species tends to home to a more 
or less specific venous plexus of the human body; S. haematobium worms tend to prefer the 
urogenital venous plexus, whereas the other species prefer the venous plexus of the 
intestinal tract [13]. A number of anastomoses exist between the pelvic venous plexuses, 
possibly affecting the final destination of the schistosome worms and ova [20]. 
 
The intravascular ova traverse the wall of the venule to enter the stroma. The ova secrete 
substances which lead to disintegration of the tissue, allowing them to pass through the 
stroma and reach the lumen of the organ in which they are deposited; frequently the lumen 
of the urinary bladder or the colon. A number of ova are frequently retained in the tissue 
stroma, and are the main cause of pathology in schistosomiasis (see 2.1.5. Histopathology). 
Figure 2. The life cycle of Schistosoma haematobium. The main aspects of the 
schistosome life cycle are similar for the species that infect humans. The snail, cercariae, 
ova, miracidium and worms have been enlarged for the sake of clarity. 
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Mature ova are excreted from the body mainly through urine (S. haematobium) or faeces (S. 
mansoni and S. japonicum). It is not yet clear whether the female genital tract also 
constitutes a route of transmission [21]. The ovum hatches when it comes in contact with 
water, liberating a miracidium. To complete the cycle, the miracidium must penetrate a 
fresh water snail (intermediate host) and develop into cercariae that are shed into the fresh 
water. Each species has its own specific snail host, which explains why the disease follows 
the distribution of the respective snails [13]. 
 
2.1.4. Clinicopathology of urinary schistosomiasis 
The World Health Organization (WHO) has recently recommended that disease caused by S. 
haematobium should be called urogenital schistosomiasis [22]. Disease caused by S. 
mansoni or S. japonicum is known as intestinal schistosomiasis [12]. This thesis will focus 
on the description of clinical features of urogenital schistosomiasis (see also 2.2. Female 
genital schistosomiasis). 
 
Urinary S. haematobium infection may cause inflammatory and calcified lesions in the 
urinary tract, leading to obstructive uropathy such as hydroureter and hydronephrosis, renal 
lesions such as acute and chronic pyelonephritis and probably a predisposition to squamous 
carcinoma of the urinary bladder [23-26]. Authors of primate and human autopsy studies 
have hypothesised that S. haematobium-induced lesions develop through three main stages; 
polypoid patches, fibrous patches and sandy patches [23,27-30]. Occasionally, reports have 
described lesions surrounded by dilated blood vessels or hyperaemia [31]. Some studies 
indicate that the degree and outcome of pathology is dependent on the focal location and 
variable intensity of infection characteristically observed in urinary S. haematobium 
infection [23,29,32,33]. 
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2.1.5. Histopathology of urinary schistosomiasis 
The histopathology caused by S. haematobium infection in general differs from that caused 
by other schistosome species [34]. In the following, mainly literature concerning S. 
haematobium infection will be cited. Results of relevant S. mansoni studies will be referred 
to only where no equivalent studies of S. haematobium exist. A more detailed account of the 
histopathology specific to female genital schistosomiasis will be given in chapter 2.2. 
Female genital schistosomiasis. 
 
Pathogenesis. S. haematobium-induced disease in humans is primarily caused by a form of 
delayed hypersensitivity reaction (type IV) to deposited ova [23,31,35]. The adult parasite 
worms evade the human immune system by adopting and integrating human antigens on 
their own surface [36]. Besides ova, dead worms, immature schistosomes and schistosomula 
may be susceptible to human immune responses [31,37]. There are, however, indications 
that adult S. haematobium worms may undergo immune-mediated clearance over time [38]. 
S. haematobium worms tend to remain in a single location for long periods, which may 
result in the deposition of large numbers of ova; up to two hundred ova daily [33,39]. 
 
More than half of the S. haematobium ova laid by the female worm may be retained in the 
tissue; characteristically found as clusters of calcified ova [33,35,40]. The intensity of 
urinary infection has been correlated to macroscopic and microscopic pathological findings, 
especially in children and young adults [23,27,35,41-43]. However, studies indicate that the 
deposition of S. haematobium ova is focal and patchy in humans and primates, although the 
variation of ova burden decreases with increasing intensity and/or duration of infection 
[24,29,33]. Moreover, factors other than the duration and density of ova deposition may 
affect the degree of pathology, such as the site and rate of ova deposition, in utero 
sensitisation to schistosome antigens, nutrition, anti-schistosomal treatment, host immune 
system, genetic predisposition and co-infections [19,44-49]. 
 
Authors of autopsy and surgical specimen studies of S. haematobium infection in Egypt 
have hypothesised that the disease develops through two main stages; ‘active’ and ‘inactive’ 
disease [27,30,42]. The active stage of disease, observed in children and teenagers, was 
characterised by mature adult worms and mostly viable ova with periovular granulation 
tissue and infiltrates of mainly lymphoid cells and eosinophils [27,28]. The inactive stage, 
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observed mostly from the third decade of life, was characterised by calcified ova and 
healing granulomas with few eosinophils [27,28]. A study of S. haematobium ova in mice 
suggests that calcifying ova may give a persistent granulomatous reaction in the tissue [50]. 
To our knowledge prospective studies of S. haematobium infection have not been performed 
in man, and thus the understanding of disease stages are hitherto based on hypotheses. 
 
Schistosomal granuloma. Several studies indicate that the periovular granuloma 
(previously termed ‘pseudotubercle’) is a common histopathological finding in urinary S. 
haematobium infection [51-56]. The schistosomal granuloma is a T lymphocyte-mediated 
immune response against miracidial products and consists predominantly of mononucleated 
cells, i.e. lymphocytes and plasma cells, monocytes, macrophages and fibroblasts, and a few 
neutrophils, eosinophils and mast cells (Table 1) [51-55]. 
 
Studies of granuloma formation in S. mansoni infection indicate that the schistosomal 
granuloma is a dynamic process in which suppressor T lymphocytes drive the 
granulomatous reaction, closely regulated by mononucleated cells [57,58]. Both T and B 
lymphocytes have been shown to be a part of the immune response against S. mansoni ova 
[59,60], and plasma cells may produce antibodies targeted at S. mansoni antigens [61]. 
Macrophages surround non-viable S. haematobium ova and ova shells are infiltrated by 
multinucleated giant cells (Table 1) [62]. Although not a dominating feature of the 
schistosomal granuloma, studies indicate that eosinophils are among the main effector cells 
in the immune defence against S. haematobium and S. mansoni [62-67]. 
 
Dendritic cells. In vitro antigen presentation by dendritic cells (DCs) may overcome T 
lymphocyte hypo-responsiveness observed in chronic S. haematobium infection [68]. In 
experimental in vitro and in vivo S. mansoni infections, DCs are competent inducers of T 
lymphocytes (Table 1) [69]. Binding of antigen to DCs, macrophages and other antigen-
binding cells may affect the polarisation of the immune response in schistosomiasis (see 
below, 2.1.6. Other immunopathological aspects) (reviewed in [70]). 
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Cell type Origin Functions 
 
 
 
 
 
Lymphocyte 
T cells originate from the 
bone marrow and mature 
in the thymus, B cells 
develop in the bone 
marrow 
T lymphocytes (CD4+, CD8+) and 
natural killer cells: cell-mediated 
immunity and immune regulation. 
B lymphocytes: humoral immunity 
(antibody production). 
 
 
 
 
 
Plasma cell 
Differentiate from 
B cells 
Produce antibodies in the host 
defence against invading 
pathogenic agents 
 
 
 
 
 
Eosinophil 
Develop and mature in the 
bone marrow 
Host immune response to 
multicellular parasites and 
involved in allergic responses 
 
 
 
Macrophage 
Monocytes from the bone 
marrow develop into 
tissue macrophages 
Engulf and digest infectious 
agents, foreign bodies and cancer 
cells. Stimulate immune cells. 
 
 
 
 
 
Giant cell 
Fusion of monocytes 
and/or macrophages 
Fusion of monocytes and 
macrophages in response to a large 
or refractory foreign body. 
 
 
 
 
 
Dendritic cell 
Originate from immature 
cells from the bone 
marrow 
Process and present antigens to 
other immune cells. 
 
 
 
 
 
Fibroblast 
Originate from the 
primitive mesenchyme 
Produce extracellular tissue 
content, such as collagen. 
Important for wound healing. 
Table 1. The main cells involved in the tissue response to S. haematobium ova [71]. 
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Other tissue reactions. Squamous epithelial hyperplasia constitutes a prominent feature of 
urinary S. haematobium infection, and may be found in association with severe urinary 
schistosomiasis [28,35]. Fibrosis may be characteristic of chronic S. haematobium infection, 
and fibroblasts have been found to adhere to fresh or partially damaged ova and produce 
extracellular collagen fibres [62]. In S. mansoni infection, fibrosis appears to be age- and 
sex-dependent [72]. 
 
2.1.6. Systemic immunopathological aspects 
At present, few appropriate experimental study models of S. haematobium infection are 
available, and most of our knowledge of the immunopathogenesis in schistosomiasis has 
been deduced from studies of murine S. mansoni infection [70]. Studies indicate that a 
closely regulated immune response against schistosomes acts to suppress the parasites’ 
virulent effects, and may further be essential for host survival [73,74]. 
 
In S. mansoni infection, the first 4-6 weeks of infection are characterised by a moderate T 
helper 1 cell (Th1) dominated immune response, followed by a shift to a T helper 2 cell 
(Th2) dominated immune reaction (reviewed in [70]). Th1 cells, a subset of CD4+ T 
lymphocytes, are recruited in response to schistosomula and immature adult worms, and 
produce cytokines such as interferon (IFN)- involved in macrophage activation [75,76]. 
Th2 cells, another subset of CD4+ T lymphocytes, are activated in response to ova 
deposition and produce interleukins such as IL-4, IL-5 and IL-13 involved in establishing 
eosinophilic and granulomatous reactions and in generating fibrosis (IL-13) [75,76]. 
Following a peak at around 8 weeks post infection, the Th2 dominant response is down-
modulated towards chronic infection [70]. IL-10 regulates the shift from Th1 to Th2 
dominant immune responses, and, alongside regulatory T lymphocytes (T regs or 
CD4+CD25+ T cells) prevents severe pathology due to excessively polarised responses [70]. 
 
The immune profile in chronic schistosomiasis, including S. haematobium infection, may 
affect the disease burden of co-infections as well as the capability to adequately respond to 
vaccines (see chapter 2.3. Schistosomiasis and human immunodeficiency virus (HIV) 
infection) [77]. On the other hand, data suggest that the immune profile in chronic helminth 
infections could protect against diseases such as asthma, allergy and autoimmunity [78-80]. 
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2.2. Female genital schistosomiasis 
2.2.1. History 
The earliest reports of female genital schistosomiasis are found in two case studies 
published in Egypt in 1899, with descriptions of schistosome ova in cervical and vaginal 
tissue, respectively [81,82]. In the years that followed, a number of case reports were 
published, and in 1925, Gibson thought it “probable that the incidence of genital 
Bilharziasis in the female is much commoner than the published reports of cases would 
suggest” [83]. 
 
Experimental studies have shown that S. haematobium infection may lead to various forms 
of pathology in the female genital tract of infected non-human primates [29,32,55,84,85]. 
Although animals show individual variations to S. haematobium infection, three main 
reactions have been identified in the genital mucosa: tan and firm polypoid patches, pale 
fibrous patches, and small, gritty sandy patches [32]. 
 
From the middle of the twentieth century a number of cross-sectional autopsy and surgical 
specimen studies were performed. Table 2 gives an overview over the main characteristics 
of the histopathological studies of S. haematobium infection in the lower female genital tract. 
Autopsy and surgical specimen studies are often biased to hospitalised and seriously ill 
patients, and the clinical relevance of the results must be interpreted as such. None of these 
studies describe the histopathology of the female genital mucosa of the controls [86-89]. 
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Author, year Material Numbera Country 
Gelfand, 1949 Autopsies   30 South Africa 
Charlewood, 1949 Surgical specimens   31b South Africa 
Badawy, 1962 Surgical specimens   68 Egypt 
Berry, 1966 Surgical specimensc   161 South Africa 
Williams, 1967 Surgical specimens   14 Nigeria 
Bland, 1970 Surgical specimens   12 Zimbabwe 
Gelfand, 1971 Autopsies   25 Zimbabwe 
Renaud, 1971 Surgical specimens   46 Ivory Coast 
Diouf, 1973 Surgical specimens   20 Senegal 
Coulanges, 1975 Surgical specimens   26 Madagascar 
Edington, 1975 Autopsies   34 Nigeria 
Koller, 1975 Surgical specimens   21 South Africa 
Loubière, 1977 Surgical specimens   51 Ivory Coast 
Bayo, 1981 Surgical specimens   51 Mali 
van Raalte, 1981 Surgical specimens   145 Tanzania 
Wright, 1982 Surgical specimens   139 Malawi 
Gouzouv, 1984 Surgical specimens   27 Republic of the Congo 
Ricosse, 1985 Surgical specimens   40 Franced 
Renaud, 1989e Community-based   46 Niger 
Helling-Giese, 1996 Out-patient departmentf   33 Malawi 
Leutscher, 1997e Community-based   12 Madagascar 
Poggensee, 2000e Community-based   134 Tanzania 
 
Table 2. Histopathological studies of human S. haematobium infection in the lower 
female genital tract. All the included studies are cross-sectional. 
aNumber of cases with schistosomiasis of the lower female genital tract by histopathological 
findings and/or digestion technique. Only studies with more than ten cases are included in 
the table. bAdditional 66 histopathological slides from other cases than those whose 
cytological results are presented. cIncludes 139 cervical smears. dInstitut de Médicine 
Tropicale du Service de Santé des Armées, Marseille. eNo detailed histopathological 
analyses other than presence or not of schistosome ova. fPatients and next of kin. 
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2.2.2. Clinical manifestations of female genital mucosal schistosomiasis 
Women with S. haematobium infection of the genital tract may suffer from pelvic pain, 
genital itch, abnormal vaginal discharge, irregular menstruation and infertility [90-92]. One 
study showed that women with genital schistosomiasis report significantly more often 
spontaneous abortions than uninfected controls [90]. S. haematobium infection of the female 
genital mucosa may present as sandy patches, with or without contact bleeding or abnormal, 
i.e. convoluted, reticular, branched and unevenly calibered mucosal blood vessels [93,94]. 
The gynaecological manifestations in women with genital S. haematobium infection may or 
may not be found together with urinary S. haematobium infection [90,93,95,96]. 
 
Female genital schistosomiasis may clinically resemble malignant lesions and/or sexually 
transmitted infections (STIs), and both may be relevant differential diagnoses [91,93]. Also 
S. mansoni and S. japonicum may infect the female genital tract, and some report findings 
similar to those found in S. haematobium infection [20,97-100]. 
 
2.2.3. Histopathology of female genital mucosal schistosomiasis 
Following the publications by Pétridis and Madden in 1899, a number of cases of S. 
haematobium infection in the female genital organs were reported [81,82,101-112]. The 
histopathological reactions vary considerably, ranging from periovular granulomas and 
infiltrates composed of eosinophils, lymphocytes, plasma cells, giant cells and fibroblasts, to 
predominantly fibrous tissue with little or no apparent periovular cellular reaction. In a 
review of female genital schistosomiasis published in 1943, Gilbert noted that the varied 
histopathological manifestations may also be found side by side in the same specimen [113]. 
 
The first systematic description of the pathogenesis in female genital S. haematobium 
infection was presented in 1919 [84]. In this study of experimental S. haematobium 
infection in monkeys, a range of tissue reactions were reported; from periovular 
multinucleated giant cells, eosinophils and small mononucleated cells to calcified ova 
surrounded by fibrotic tissue [84]. 
 
Autopsy and surgical specimen studies. The histopathology of human female genital S. 
haematobium infection has been explored in a number of autopsy and surgical specimen 
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studies from all regions of Africa (see Table 2) [86-89,114-127]. It must be noted that most 
studies have not controlled for STIs. The organ distribution of S. haematobium ova in 
infected women varies between studies; however, the lower genital tract is the most frequent 
detection site in biopsies, commonly taken from the cervix by routine sampling and/or as 
part of cancer diagnostics [87-89,115,117-120,123-126]. 
 
In a study of surgical specimens from South Africa, Charlewood et al noted a marked 
variation in the morphological reaction to schistosome ova; from slight reactive changes to 
chronic inflammation, often with abscesses of eosinophils [114]. The authors also remarked 
that the tissue reaction was not necessarily related to the density of ova in tissue, as in some 
cases “the degree of response appears to be out of all proportion to the number of ova 
found” [114]. Infected tissue lined by squamous epithelium, such as the vulva, vagina and 
ectocervix, often showed hyperplastic changes and papilloma formation of the epithelium, 
whereas tissue lined by columnar epithelium showed little or no epithelial reaction. 
 
In a study in Egypt, Badawy suggested that so-called schistosomal pseudotubercles; 
consecutive layers of epithelioid cells, eosinophils and lymphocytes surrounding an ovum 
engulfed by a giant cell, were characteristic for S. haematobium infection of the cervix [115]. 
Squamous epithelial hyperplasia and gradual replacement of ‘pseudotubercles’ by fibrosis 
were other characteristics associated with cervical S. haematobium infection [115]. 
 
A large variation in histopathological findings was also reported by Berry in 1966 [86]. 
Schistosome ova, most often deposited in the subepithelial tissue of the transformation zone, 
were commonly surrounded by increased vascularity, ‘pseudotubercles’, eosinophilic 
reaction, ulceration, lymphocyte infiltrates, multinucleated histiocytes and epithelial 
hyperplasia. However, the periovular tissue reaction could also show little or no apparent 
involvement at all [86]. Comparing the histopathological findings to an analysis of cervical 
and vaginal smears of other cases, the author “felt that ova (which could often be seen 
escaping) could have been retrieved in smears” [86]. Others report the findings of S. 
haematobium ova close to denuded or atrophic epithelium and in cytological material 
[21,105,116,128]. However, one study suggests that cervical smears are unreliable for the 
diagnosis of female genital schistosomiasis [129]. 
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Categories of histopathogical changes. In a detailed and systematic analysis of surgical 
specimens from Ivory Coast, Renaud et al suggested that tissue reactions to female genital S. 
haematobium infection develop through three main stages: ‘exudative’, ‘productive’ and 
‘sclero-cicatricial’ [87]. The exudative stage was characterised by abundant 
neovascularisation and numerous micro-abscesses containing neutrophils and eosinophils, 
lymphocytes, histiocytes and red blood cells surrounding an often viable schistosome ovum. 
The second, productive stage was characterised by the apparition of ‘pseudotubercles’ 
around both viable and non-viable schistosome ova. Finally, the sclero-cicatricial stage was 
characterised by dense fibrous tissue with scattered giant cells, few ova remnants without 
any apparent periovular reaction. The authors also frequently found hyperplastic changes of 
the squamous epithelium in the S. haematobium infected genital mucosa [87]. 
 
In line with the findings by Renaud et al, a retrospective analyses of surgical specimens in 
Malawi identified five different tissue reactions to schistosome ova: 1) diffuse infiltration by 
eosinophils, neutrophils, plasma cells, lymphocytes and macrophages, 2) granulomas or 
pseudotubercles with epithelioid cells, lymphocytes, eosinophils and fibroblasts, 3) foreign 
body giant cells surrounding shell fragments, 4) large numbers of shell fragments trapped in 
fibrous tissue and 5) sparse shell fragments with no apparent tissue reaction [118]. The 
authors hypthesised that the different categories represented different phases of progress of 
S. haematobium-induced histopathology [118]. 
 
The results of the first community-based study were published in 1989 by Renaud et al 
[120]. Vaginal biopsies were sampled from 61 otherwise unselected Nigerien women, 
identifying a prevalence of vaginal schistosomiasis of 75%. In line with previous studies 
[89,117], Renaud et al found that the intensity of urinary S. haematobium infection as 
measured by urinary ova output and vesical lesions detected by ultrasound, was significantly 
associated with vaginal S. haematobium infection [120]. 
 
Most of the studies discussed above describe a diversity of histopathological tissue reactions 
to schistosome ova, however, in a number of studies, the majority of cases are limited to a 
moderate to mild tissue reaction [89,117,119,123,124,126]. No study has yet explored the 
possible pathophysiological mechanisms for this variation of tissue reactions. 
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Ova detection in tissue specimens. The deposition of S. haematobium ova in the female 
genital mucosal tissue may be highly focal and affect the analyses of the related tissue 
reactions [89,113,114]. Several studies have explored the ability of tissue digestion with 
potassium hydroxide as a detection method of schistosome ova [89,113,117,130]. A 
digestion study in 30 consecutive autopsies in South Africa found S. haematobium ova in 
the genitals of all the cases [130]. In a retrospective autopsy study in Nigeria, complete 
digestion and histopathological findings were compared in the pelvic organs in 34 females 
with urinary S. haematobium infection, and the two ova detection methods proved to 
perform well in severe infections, whereas the ability to detect ova by histopathology was 
reduced compared to digestion technique in milder infections [117]. However, a 
Zimbabwean study of block dissections of the pelvic organs from 64 consecutive autopsies 
concluded that neither digestion nor histological examination was sufficient to successfully 
detect ova in the tissue [89]. 
 
2.2.4. Clinicopathological correlates 
A clinicopathological, hospital-based study in Malawi from 1994, which correlated 
histopathological results with clinical findings in female genital S. haematobium infection, 
indicated that sandy patches consist of ova in various stages of disintegration surrounded by 
a limited cellular reaction, and that polyps consist of a more pronounced immune reaction 
with a cellular infiltrate [127]. These findings correspond with an experimental study of 
urogenital S. haematobium infection in baboons in which polypoid patches; sharply 
delimited, resilient patches, were found to consist of large numbers of ova with infiltrates of 
eosinophils, macrophages, plasma cells and lymphocytes; fibrous patches of fibrosis with 
some inflammation; and sandy patches of closely packed ova with little inflammation [32]. 
 
Although the abovementioned findings may be plausible, no other clinical or experimental 
evidence definitely supports the hypothesis that acute schistosomal lesions evolve into 
sandy patches [42]. However, the hypothesis is supported by the findings of what is 
regarded as acute pathology in children and teenagers with urinary S. haematobium 
infection, and what is thought to be progressive pathology in adults [23,27,28,131]. 
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2.3. Schistosomiasis and human immunodeficiency virus (HIV) infection 
Recently, the possible association between schistosomiasis and HIV infection has received 
increased attention [132-135]. On the one hand, concomitant HIV infection could affect 
schistosomal morbidity or susceptibility to schistosome infection, and on the other hand, 
concomitant schistosomiasis could affect HIV-related morbidity or risk of HIV transmission 
[136,137]. To our knowledge, there are no studies of HIV-2 infection and schistosomiasis. 
In the following HIV-1 will be referred to as HIV. 
 
2.3.1. The female genital mucosa and HIV transmission 
The lower female genital tract is the main site of HIV transmission, and is also one of the 
most common sites for female genital S. haematobium infection [93,138]. Similar to STIs, it 
has been suggested that genital lesions caused by S. haematobium ova may provide points of 
entry for HIV [133,139-142]. Studies have been demonstrated that S. haematobium 
infection may compromise the barrier function of the female genital mucosa 
[86,93,94,118,143]. 
 
Studies indicate that CD4+ T cells, Langerhans cells and macrophages are among the 
earliest cervicovaginal cell populations to be infected with HIV [144-149]. Further, HIV co-
receptors CCR5 and CXCR4 may be necessary for the propagation of HIV infection 
[150,151]. It has been hypothesised that S. haematobium induced immune reactions in the 
genital mucosa could increase the density of HIV susceptible immune cells [133,152]. This 
could potentially facilitate the transmission of HIV in co-endemic areas [153]. 
 
2.3.2. Epidemiological data on schistosomiasis and HIV infection 
Several aspects of the uneven burden of the HIV epidemic warrant further understanding of 
the possible factors responsible for driving the epidemic [152]. A disproportionately high 
HIV prevalence affects Sub-Saharan Africa, and there appears to be a geographical overlap 
between co-endemic areas for HIV and S. haematobium infection [22]. Further, there is an 
unexplained gender quotient disfavouring women, especially in younger age groups [154]. 
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2.3.3. Immunological data on schistosomiasis and HIV infection 
HIV more readily infects and replicates in Th2 lymphocytes, and the Th2-dominated 
immune response in chronic schistosomiasis might increase HIV-related morbidity in 
concomitant schistosomal infection (see 2.1.6. Other immunopathological factors) 
[132,155,156]. In vitro peripheral mononuclear blood cells from S. mansoni infected 
individuals were more susceptible to HIV infection than mononuclear blood cells of non-
infected individuals [157]. Furthermore, CD4+ cells in patients with S. mansoni infection 
expressed a higher density of HIV co-receptors CCR5 and CCXR4 than did CD4+ cells in 
patients treated for schistosomiasis [158]. 
 
On the other hand, studies indicate that CD4+ T lymphocytes may be essential for the host 
response to S. mansoni infection, and some suggest that a depletion of CD4+ cells in HIV 
infection could increase schistosomal morbidity and affect susceptibility to schistosomal re-
infection [73,74,137]. Moreover, ova excretion may be reduced in schistosomiasis and HIV 
co-infected, thereby possibly increasing ova-related pathology [159,160]. A cross-sectional 
study, however, did not find any difference in egg excretion between low-intensity 
schistosomiasis and HIV co-infected patients and patients with schistosomiasis alone [161]. 
Studies suggest that Th17 cells may affect the mucosal immune response in HIV-1 infection; 
however, their role has not yet been explored in schistosomiasis [70,162,163]. 
 
2.3.4. Clinical data on a possible association with HIV infection 
A cross-sectional, community-based study in Zimbabwe found a nearly three-fold increased 
odds of HIV infection in women with genital S. haematobium infection compared to women 
without [135]. Women with urinary S. haematobium infection were more often co-infected 
with HIV infection than women without urinary schistosomiasis [164]. These findings are in 
line with the results from an experimental study of S. mansoni infected rhesus monkeys, in 
which the infectious dose of simian-human immunodeficiency virus was 17-fold lower in 
parasitised compared to non-parasitised animals [165]. 
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2.4. Computer-assisted image analysis 
Quantification of immunostained cells and tissue structures in formalin-fixed, paraffin-
embedded tissue sections is a core element of histopathological methodology [166,167]. In 
many laboratories, immunohistochemical quantification is still mostly performed manually, 
both in routine and research pathology. This procedure is time-consuming and tiring, and 
the results may be compromised by intra- and inter-observer variabilities [167]. 
 
Computer-assisted image analysis can improve the reliability and validity of quantitative 
analyses of immunostained tissue sections [168-171]. Costly software has been customised 
for specific clinical purposes; however, there is a need for simple and comprehensible 
models for low-cost computer-assisted image analyses [172]. 
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3.0. Study objectives 
3.1. Broad objectives 
The aim of this study was to explore the histopathological and immunohistochemical factors 
which might affect cervicovaginal HIV susceptibility, and to explore the histopathological 
correlates of clinical findings in female genital mucosal S. haematobium infection. 
 
3.2. Specific objectives 
A. To develop a simple method for precise computer-assisted quantitative analyses of 
immunostained formalin-fixed and paraffin-embedded tissue sections (Paper IV). 
 
B. To study the histopathological and immunohistochemical tissue reactions immediately 
surrounding S. haematobium ova in cervicovaginal mucosal biopsies, by 
1. quantifying and determining the characteristics of periovular endothelial cell 
structures (Paper I). 
2. quantifying the density of periovular CD4+ T lymphocytes, macrophages, 
Langerhans cells and CCR5 and CXCR4 receptors (Paper II). 
 
C. To explore the histopathological correlates of abnormal mucosal blood vessels in 
cervicovaginal S. haematobium infection (Paper III). 
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4.0. Materials and methods 
4.1. Study population and design 
The analyses were performed on endemic archive biopsies from a study in Malawi and on 
non-endemic archive biopsies from Norway (Figure 3). An overview of the study groups is 
shown in Table 3. One of the patients presented in the case study (Paper III) originated from 
a cross-sectional study in Madagascar which will be described at the end of this section. 
 
Non-endemic 
normal cervix 
Endemic without 
FGSa 
Endemic 
with FGSa 
Non-endemic 
chronic cervicitis 
No S. haematobium 
ova seen 
No S. haematobium 
ova seen  
S. haematobium ova 
identified 
No S. haematobium 
ova seen 
Less than 10 immune 
cells per HPFb 
 
  Predominance of 
plasma cells and/or 
lymphocytes 
No non-specific 
tissue proliferation 
 
  Less than 20 PMNsc 
and less than 5 
eosinophils per HPFb 
No other signs of 
pathology 
  No other signs of 
pathology 
 
Table 3. The study groups. The histopathological characteristics of endemic Malawian and 
non-endemic Norwegian biopsies included in the study. aFGS = Female genital mucosal S. 
haematobium infection. bHPF = high-power field. cPMN = polymorphonuclear neutrophil. 
 
Endemic cases and controls. The archive biopsies of endemic cases and controls originated 
from a study of women with urogenital S. haematobium infection at Mangochi District 
Hospital in Malawi in 1994 [173]. All sexually active women between 15 and 49 years of 
age, irrespective of their complaints or whether they were patients or next of kin, present in 
the out-patient department before lunch time, were invited to submit urine samples. Women 
who were willing to provide a urine sample, and who by filtration of the urine were found to 
have S. haematobium ova in the urine, were invited for an interview and gynaecological 
examinations. 
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Figure 3. Archive biopsies from an S. haematobium endemic study site (Mangochi) were 
analysed with Norwegian archive biopsies as non-endemic controls. 
 
Women who declined a gynaecological examination or biopsy, virgins, pregnant women (as 
indicated by the medical history and confirmed by human chorionic gonadotropin (hCG) 
test in urine) and postmenopausal women were excluded from the study. Excluded women 
were offered equal medical services and referred to the hospital staff if necessary. Pregnant 
women with schistosomiasis were asked to come back for treatment after delivery. 
 
Following free and informed consent, a gynaecological examination was performed. 
Cervical biopsies were taken routinely. In total, biopsies from the cervix and/or vagina were 
sampled from 61 women. The pathology was photographed using a portable 
photocolposcope (Leisegang Medical, Berlin, Germany). Results from analyses of HE-
stained biopsies and of other specimens collected in 1994 have been published previously 
[127]. All women with urogenital schistosomiasis were weighed and offered supervised 
treatment with a single dose of praziquantel 40 mg/kg body weight. 
 
Malawian women with S. haematobium ova in genital mucosal biopsies were included as 
endemic cases, whereas Malawian women without S. haematobium ova in genital mucosal 
biopsies served as endemic negative controls. In order to avoid undetected ova situated just 
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outside the biopsy borders in presumed negative cases (Figure 4), only women without S. 
haematobium ova in genital mucosal biopsies in both the original and present studies were 
included as endemic negative controls. A previous study has indicated an association 
between HPV and urogenital S. haematobium infections; however, specific signs of HPV 
infection were not observed in the endemic biopsies with S. haematobium ova [174]. In 
addition to the cervical biopsies, three vaginal biopsies were included. The histopathological 
reactions and ova viability were similar in the cervical and vaginal biopsies, and the biopsies 
were therefore analysed together. 
 
 
 
Figure 4. Ova location and tissue sectioning. Due to focal deposition in the tissue, S. 
haematobium ova may be missed by only a few micrometres and the possibility of 
remaining ova-related histopathology might be misinterpreted. 
 
Non-endemic controls. Non-endemic Norwegian archive biopsies were selected by 
searching the database at the Department of Pathology at Oslo University Hospital Ulleval 
from 1994 for combinations of the anatomical site ‘cervix uteri’ and the morphological 
diagnoses ‘cervicitis’ and ‘normal morphology’. Included as negative non-endemic controls 
were women with histologically normal uterine ectocervices with intact tissue architecture 
(Figure 5). Excluded were all endocervical biopsies, and ectocervical biopsies with more 
than ten inflammatory cells per high-power field (HPF), non-specific vessel proliferation, 
epithelial hyperplasia, polyps, cysts, atypical or dysplastic changes, or signs of human 
papilloma virus (HPV) infection, i.e. clustered koilocytosis and dyskeratosis. 
 
B A 
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Included as positive non-endemic controls were women with chronic non-specific cervicitis; 
defined as ectocervices with intact tissue architecture and a distinct, generalised infiltrate 
dominated by lymphocytes and/or plasma cells (Figure 6). Excluded were all endocervical 
biopsies, and ectocervical biopsies with more than 20 granulocytes or 5 eosinophils per HPF 
and specimens with signs of HPV infection, erosion, ulcerations, granulation tissue or extra-
vascular erythrocytes (in order to avoid non-specific immunostaining). 
 
For each immunostain, different numbers of biopsies were available in the respective study 
groups (Table 4). Endemic biopsies were excluded due to insufficient tissue for further 
analyses and when ova lacked in subsequent sectioning. Non-endemic biopsies were 
excluded due to technical reasons such as non-specific cross-reactions and insufficient tissue 
with preserved architecture. The limited number of available biopsies restricted the 
possibility for stratification by age, and this is addressed during the statistical analyses. 
 
Immunostain 
(antibodies) 
Non-endemic 
normal cervix 
Endemic 
without FGSa 
Endemic 
with FGS 
Non-endemic 
chronic cervicitis 
 Incl Excl Incl Excl Incl Excl Incl Excl 
vWFb 28 1 24 0 20 17 11 7 
CD31c 29 0 24 0 20 17 15 3 
CD3/8 29 0 16 8 13 24 16 2 
CD68 29 0 23 1 19 18 18 0 
S100 28 1 14 10 17 20 15 3 
 
Table 4. Included and excluded specimens. Biopsies were excluded for technical reasons 
such as insufficient tissue for further analyses or lack of ova in subsequent sectioning of 
endemic biopsies with previously detected S. haematobium ova. aFGS = Female genital 
mucosal S. haematobium infection. bvWF = von Willebrand Factor (previously Factor VIII 
Related Antigen). cCD = Cluster of differentiation. 
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Figure 5. Non-endemic negative control. Archive biopsies of non-endemic Norwegian 
women with normal cervices were included as negative controls. 
 
 
 
 
Figure 6. Non-endemic positive control. Archive biopsies of non-endemic Norwegian 
women with non-specific chronic cervicitis were included as positive controls. 
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The Madagascan study. A population-based cross-sectional study was carried out in 
women between 15 and 35 years of age in the district of Miandrivazo in Western 
Madagascar in June and July of 2010. The surfaces of the lower genital tract were examined 
in a standardised manner, and accurate biopsies were sampled from observed pathology 
using biopsy forceps 2.3 mm (ENDO-FLEX GmbH, Voerde, Germany). The precise 
location of the biopsy was recorded using a pointer and photographed using an Olympus E-
420 10 megapixel single lens reflex (SLR) camera (Olympus America Inc., Center Valley, 
PA, USA) mounted on an Olympus OCS-500 colposcope (Olympus America Inc.) in order 
to correlate the clinical findings with the histopathological results. Standard 
histopathological examinations were performed on the Madagascan biopsies. 
 
4.2. Histopathology 
All biopsies were fixed in formalin, routinely processed and embedded in paraffin. For 
histopathological analyses, 3.5 m serial sections of the included specimens were cut using 
a Microm HM 355 microtome (Thermo Fisher Scientific Inc., Waltham, Massachusetts, 
USA) and placed on SuperFrost slides (Menzel-Gläser, Braunschweig, Germany). The 
sections were deparaffinised and rehydrated prior to standard HE staining. 
 
4.3. Immunohistochemistry 
For immunohistochemical analyses of the Malawian biopsies, 3.5 m thick serial sections of 
the included specimens were cut using a Microm HM 355 microtome (Thermo Fisher 
Scientific) and placed on SuperFrost Plus slides (Menzel-Gläser). The 
immunohistochemical stains were performed using BenchMark XT (Ventana Medical 
Systems Inc., Tucson, Arizona, USA); an automated immunostain system based on the ABC 
avidin-biotin-peroxidase method. 
 
The automated slide preparation system performed sequential deparaffinisation, antigen 
retrieval, and incubation with primary and secondary antibodies, respectively. Enzyme-
mediated horseradish peroxidase (HRP) labelled to diaminobenzidine (DAB) reporter 
molecules was used for colour detection. Amplification was achieved by secondary 
antibody conjugation to biotin molecules and by avidin protein bound enzymes. All sections 
were counter-stained with haematoxylin. Optimal antigen retrieval, antibody concentrations 
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and incubation times were pre-tested on endemic and non-endemic specimens for each 
immunostain. Table 5 shows the specifications and final dilutions used for each 
immunostain. Negative and positive controls were included for analyses according to 
manufacturer recommendations. All slides were examined microscopically by a senior 
pathologist (BR) for immunohistochemical antigen detection combined with morphological 
identification. 
 
The immunostains were specifically chosen in order to meet the respective study objectives. 
For the identification of blood vessels, two endothelial cell markers were used; monoclonal 
antibodies to CD31 (Dako Denmark A/S, Glostrup, Denmark) (Figure 7) and polyclonal 
antibodies to von Willebrand Factor (vWF) (Ventana) (Figure 8). In line with previous 
reports, immunohistochemical antibodies to CD4, CCR5 and CXCR4 cross-reacted non-
specifically and could not be interpreted (Figure 9). For identification of CD4+ T 
lymphocytes, a mature T lymphocyte marker and a cytotoxic T cell marker were applied on 
two consecutive 3.5 m thick serial sections of each biopsy; rabbit monoclonal antibodies to 
CD3 (Ventana) (Figure 10) and mouse monoclonal antibodies to CD8 (Dako), respectively 
(Figure 11). Macrophages were identified using mouse monoclonal antibodies to CD68 
(Dako) (Figure 12) and Langerhans cells were identified using rabbit polyclonal antibodies 
to S100 protein (Ventana) (Figure 13). 
 
All specimens were originally stored in formalin. Further analyses of receptor expression or 
activity other than HE and immunohistochemical staining could thus not be performed. 
Enzyme immunohistochemical analyses were preferred to immunofluorescence techniques, 
in order to allow for visualisation of tissue architecture and thereby the relative location of 
the respective tissue reactions to S. haematobium ova. 
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Antigena Antibodyb Clonec Manufacturer Dilution Incubationd 
CD31e Monoclonal, mouse JC70A Dakof 1/80 32’ 
vWFg Polyclonal, rabbit - Ventanah Ready to usei 20’ 
CD4 Monoclonal, mouse 1F6 Leicaj 1/10 36’ 
CD3 Monoclonal, rabbit 2GV6 Ventana Ready to usei 32’ 
CD8 Monoclonal, mouse C8/144B Dako 1/150 30’ 
CD68 Monoclonal, mouse KP1 Dako 1/3000 32’ 
CD14 Monoclonal, mouse 7 Leica 1/15 40’ 
CCR5k Polyclonal, rabbit - AbD Serotecl 1/60 32’ 
CXCR4m Polyclonal, rabbit - AbD Serotec 1/50 32’ 
S100 Polyclonal, rabbit - Ventana Ready to usei 16’ 
 
Table 5. Antigen markers used for immunohistochemical staining. aTarget antigen. 
bAntibody characteristics. cClone number of monoclonal antibodies. dIncubation time 
(minutes) of primary antibody. eCD = Cluster of differentiation. fDako Denmark A/S, 
Glostrup, Denmark. gvWF = von Willebrand Factor (previously Factor VIII Related 
Antigen). hVentana Medical Systems Inc., Tucson, Arizona, USA. iNo dilution needed prior 
to application. jLeica Biosystems Newcastle Ltd., Newcastle Upon Tyne, UK. kAlso named 
CD195. lAbD Serotec, Oxford, UK. mAlso named CD184. 
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Figure 7. Capillary budding in tissue with S. haematobium ova. Immunostain to CD31 of 
sprouting of capillary buds (brown) surrounding several calcifying ova. Note the viable, 
intravascular ovum (left) and the ovum undergoing digestion by a multinucleated giant cell. 
 
Figure 8. Established blood vessels in tissue with calcified S. haematobium ova. 
Immunostain to vWF clearly demarcates established blood vessels (brown) surrounding a 
cluster of calcified ova 
S. haematobium 
ova 
Giant cell 
digesting an 
S. haematobium 
ovum 
Cluster of 
calcified S. 
haematobium ova 
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Figure 9. Non-specific protein detection. Immunostain of endemic biopsy with antibodies 
to CD4 (A) and CCR5 (B) stain non-specific epitopes on ova and other structures and could 
therefore not be interpreted. Similar results were seen for antibodies to CXCR4 (not shown). 
Non-specific 
immunostain 
Non-specific 
immunostain 
S. haematobium 
ova 
A 
B 
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Figure 10. CD3 immunostain. Section of biopsy with CD3+ T lymphocytes (brown) 
surrounding S. haematobium ova (3.5 m above the next serial section (Figure 11)). 
 
 
Figure 11. CD8 immunostain. The consecutive section of the same biopsy as in Figure 10 
(3.5 m below the previous section). 
S. haematobium 
ova 
Immunostain to 
CD3 (brown) 
Immunostain to 
CD8 (brown) 
S. haematobium 
ova 
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Figure 12. Macrophages in S. haematobium infected cervical mucosa. Immunostain to 
CD68 demonstrates tissue macrophages (brown). Note the fusion of macrophages (giant cell) 
surrounding a viable S. haematobium ovum. 
 
 
Figure 13. Dendritic cells in female genital mucosa. Immunostain to S100 protein 
visualises dendrites of Langerhans cells (brown). S. haematobium ova are located 
immediately beneath the analysed epithelium (other sections, not shown). 
Viable S. 
haematobium ova 
Macrophages 
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Identification of ova spines is deemed insufficient for determination of schistosome species 
in tissue specimens [86]. A modified Ziehl-Neelsen stain (VWR International, LLC, Radnor, 
Pennsylvania, USA) was therefore used to distinguish S. haematobium type ova from S. 
mansoni or S. intercalatum ova (Figure 14) [175]. In addition, characteristic features such as 
ova clustering and calcification contributed to the identification of S. haematobium type of 
schistosome ova [86]. 
 
 
Figure 14. Species identification of S. haematobium ova. A modified Ziehl-Neelsen stain 
developed by Rousset et al distinguishes S. haematobium ova (dark blue) from other 
schistosome ova (none identified in these study populations). 
 
4.4. Microscopy and photomicrography 
The sections were examined using a Nikon Eclipse 80i and a Leica DM3000 microscope 
with standard illumination. The former was used for histopathological analyses and 
immunohistochemical analyses of blood vessels, whereas the latter was used for 
immunohistochemical analyses of immune cells. The change of microscopes was due to 
logistics at the department where the analyses took place. The sections were photographed 
at 40x objective magnification using a SPOT Insight 2 Megapixel Firewire Color 3-shot and 
S. haematobium 
ova 
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a Leica DFC420 digital camera digital camera, respectively. The cameras were attached to 
the respective microscope and a Hewlett-Packard Compaq stationary computer. Colour 
photomicrographs of 1600 by 1200 pixels and 2592 by 1944 pixels, respectively were 
obtained. 
 
The morphological and immunohistochemical analyses and photomicrographs were 
performed in a standardised manner. Blinded for the immunostain results, the candidate 
evaluated the HE-stained sections. An HPF of the HE-stained sections of the endemic 
biopsies with S. haematobium ova was photographed with the ovum or ova placed centrally. 
The area of tissue surrounding the ovum or ova in one such photograph was defined as 
‘periovular’. To study the histopathology directly adjacent to the ova, and to avoid the 
possible influence of undetected ova just outside the biopsy borders, the sections were 
photographed only in areas containing ova (see Figure 4). In biopsies with more than one 
cluster of ova, the most representative area for the respective biopsy’s tissue reaction was 
included. The control biopsies were photographed in a subepithelial area representative for 
the pathologist’s overall diagnosis of the biopsy. The subepithelium was chosen since this is 
the most common location for female genital mucosal S. haematobium ova [86]. 
 
Once the HE-stained sections had been analysed and photographed, the near-exact same 
areas of the consecutive immunostained serial sections were photographed, identified by 
histological anatomical structures. All sections were examined microscopically and all 
photographs evaluated by an experienced pathologist (BR). The area of S. haematobium ova 
and by extra-mucosal space was estimated for the respective photomicrographs by 
superimposing a centimetre grid on the computer screen. 
 
S. haematobium ova were defined as ‘viable’ if miracidia with eosinophilic glands or 
germinal cells were seen [86], whereas ova containing dark purple stain identified 
histologically as calcification were defined as ‘calcified’. The histopathological tissue 
reaction was defined as ‘granulation tissue’ if dominated by capillary buds with activation 
of endothelial cells and immature fibroblasts. The tissue reaction was defined as ‘fibrosis’ if 
dominated by collagen rich stroma with scant mature fibroblasts. 
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4.5. Manual immunohistochemical quantification 
The heterogeneous immunostaining and diverse topographical distribution of endothelial 
cell structures and Langerhans cells required manual analyses for accurate quantification. 
Although the specimens were evaluated several times by two investigators who attempted to 
be objective, blinding was not possible due to the presence of schistosome ova and the 
respective immunostains. 
 
Immunostained blood vessels (by vWF and CD31 (Figures 7 and 8)) were counted in 
accordance with pre-established criteria [176,177]. ‘Capillary buds’ were defined as 
immunostained vessel structures without an identifiable lumen or peri-endothelial structures, 
whereas all other stained vessel structures were counted as ‘established blood vessels’. The 
density of capillary buds and vessels were calculated per mm2 cervicovaginal tissue, 
correcting for the space made up by ova and extra-mucosal space. In sections with more 
than 300 capillary buds per mm2, the numbers were truncated to 300. 
 
For quantification of Langerhans cells (Figure 13), the epithelium of the 
immunohistochemically stained sections was photographed at 40 times objective 
magnification and reconstructed using Adobe® Illustrator® CS5 software (Adobe Systems 
Inc., San Jose, CA, USA). Langerhans cell structures were counted manually in an area 
equivalent to one HPF to each side of the epithelium overlying the original photograph of 
the HE-stained section (Figure 13). Counted were only immunohistochemically stained 
epidermal structures with distinct demarcation and immunostained cells with distinct 
dendritic processes located in the basal and parabasal strata (Ventana, USA). 
 
The immunostained structures in each photograph were counted manually by the candidate, 
and one in ten randomly selected photographs of immunostains to endothelial cell structures 
were quality controlled by a senior pathologist (BR). The immunostain to Langerhans cells 
showed a larger variation and therefore every third photograph was counted by the senior 
pathologist. Discrepancies were resolved by consensus, if necessary after consulting a 
second senior pathologist. Finally, each photograph was recounted. 
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4.6. Computer-assisted immunohistochemical quantification 
Stromal immune cells were distinctly immunostained with antibodies to CD3, CD8, and 
CD68. Following pre-defined criteria, two independent investigators counted manually a 
random selection of ten photomicrographs of each immunostain. Immunostained 
cytoplasma or membrane structures of at least the average diameter of a lymphocyte and/or 
immunostained perinuclear cell structures were counted. For the quantification of T 
lymphocytes, non-intact cell structures histopathologically identified as apoptotic cell 
fragments were registered separately. 
 
Macros (computer algorithms) were developed for computer-assisted image analysis using 
ImageJ version 1.44p; a Java image processing application available at the website of the 
National Institutes of Health (NIH) [168,172,178,179]. A macro was developed for the 
respective immunostain to quantify the number of immunostained cells in each series of 
photomicrographs, based on the average manual counts as described above. Results were 
given as the density of separate cells for T lymphocytes and as the area of macrophages; 
correcting for the area made up of ova and extra-mucosal space. An outline of the final 
structures was superimposed on the original photographs and manually validated. The 
results were verified by a senior pathologist, and a second senior pathologist was consulted 
if necessary. 
 
A three step algorithm for computer-assisted image analysis of immunostained tissue 
structures was developed. In step one, the immunostained structures are identified by 
selecting the colour properties which correspond best to the structures of interest. This is 
achieved using a perceptive colour model in which a specific colour is defined by its 
respective hue, saturation and brightness (HSB). The structures of interest are isolated based 
on the intersection of selected threshold intervals in each colour channel. Such a perceptive 
colour model has the advantage of being more intuitive to the human eye than a purely 
technical colour model such as red, green and blue (RGB) or cyan, magenta, yellow and key 
black (CMYK). The selected structures are measured (step two) and the results verified 
(step three). A macro may then be recorded based on the average threshold values and 
applied for analysis of any number of immunostained tissue sections. 
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4.7. Data analyses 
4.7.1. Sample size calculation 
The effect of S. haematobium on genital cell receptor expression has not previously been 
explored. Based on previous studies of HIV co-receptors in sexually transmitted genital 
ulcers [139,150], we assumed that the true average percentage of HIV target cells would be 
11% in the endemic cases with genital schistosomiasis, and that the standard deviation (SD) 
of percentage of HIV target cells would be 2.5% in both endemic cases and controls. We 
assumed that the true average percentage of HIV target cells would be 5% and the SD 3% in 
the non-endemic controls. The available study samples consisted of between 18 and 29 
subjects in each group. It may be shown that the study will have 80% probability (test power) 
to detect a significant difference in percentage of HIV target cells between the groups and 
the test power will be sufficient. 
 
4.7.2. Statistical analyses 
The statistical analyses and sample size estimation were performed with SPSS version 16.0 
and PS Power and sample size calculations version 2.1.31. Most variables were not 
normally distributed and non-parametric tests were therefore used when studying 
associations. Medians and interquartile ranges (IQR) were used to describe the results. The 
Mann-Whitney U and Kruskal-Wallis H tests were applied where appropriate. For the 
calculation of odds ratio (OR), it was necessary to tertilise the not normally distributed 
variables. Spearman’s rank correlation coefficient was used when studying associations 
between continuous variables. Intra-observer variability was determined by calculating the 
intra-class correlation coefficient (ICC) after log-transformation of the data. A 5% 
significance level was used throughout. 
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4.8. Ethical considerations 
Permissions for the histopathological and immunohistochemical investigations of 
anonymised archival Malawian and Norwegian biopsies, without additional consent from 
the study subjects, were granted by the National Health Science and Research Committee of 
Malawi (2009/NHSRC #620) and the Norwegian Regional Ethics Committee (2009/1250a). 
The permissions were based on the fact that the proposed analyses did not require 
identifiable information or history, did not have any direct relevance to the physical, mental 
or social well-being, and did not have any direct diagnostic or therapeutic implications for 
the study women. Permissions for the study in Madagascar were obtained from the 
Ministère de la Santé, Comité d’Ethique No 031-CE/MINSAN. The histopathological 
examinations of the Madagascan biopsies were performed by the Department of Pathology, 
Rigshospitalet, Copenhagen. 
 
Study information was provided to the study populations in the local languages. 
Participation in the studies was voluntary, and free informed consent was obtained. Each 
study participant went through an information session with a female nurse or medical doctor 
about the purpose of the study, the procedures, the benefits and negative consequences of 
participation, confidentiality and the possibility to withdraw at any point during the 
investigations. To assess the participants’ understanding, the clinician posed control 
questions to the women. The women were allowed to ask questions at any time. All 
investigations were performed after further oral permission re-ascertained by the physician 
before each step of the investigations and sampling. 
 
Women who withdrew from study participation received the same possibility of health 
support. All women, including those who declined further investigations, were offered 
treatment with praziquantel. Treatment and follow-up for schistosomiasis, STIs, cancer and 
other conditions were given in collaboration with the local health care professionals. All 
non-endemic controls were followed up by the referring clinician in Norway. 
 
There are some concerns associated with sampling of biopsies from women with genital 
mucosal S. haematobium infection. A biopsy of the female genital mucosa will disrupt the 
mucosal barrier and might increase the risk of HIV infection and other STIs. In these studies, 
only superficial biopsies were taken and vascular lesions were avoided (Dr. Kjetland, 
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personal communication). The participating women were not asked for HIV testing. 
Participating women were asked if they could abstain from sex or would consistently use 
condoms for two weeks following a possible biopsy. Biopsies were performed in women 
with lesions only and were confined to a few millimetres of the observed pathology. 
Occasionally, more than one biopsy was taken if the procedure did not discomfort the 
woman. Each biopsied woman was offered condoms in the examination room. All data, 
specimens, paper and digital documentation were coded. The connection list between the 
data and personal identities was stored securely. 
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5.0. Summary of articles 
Paper I 
Increased vascularity in cervicovaginal mucosa with Schistosoma haematobium infection 
Jourdan PM, Roald B, Poggensee G, Gundersen SG, Kjetland EF. 
PLoS Negl Trop Dis. 2011 Jun;5(6):e1170 
 
Background. Female genital mucosa infected with S. haematobium may appear inflamed 
with abnormal mucosal blood vessels, and may provide mucosal points of entry for HIV. 
The aim of this study was to quantify and analyse the characteristics of the blood vessels 
surrounding S. haematobium ova in mucosa of the lower female genital tract. 
 
Methods. Cervicovaginal biopsies with S. haematobium ova (n=20) and control biopsies 
(n=69) were immunostained with CD31 and von Willebrand Factor (vWF), which stain 
endothelial cells in capillary buds and established blood vessels, respectively. 
 
Results. S. haematobium ova were found in 44% (20/45) of the Malawian women, with a 
median of 3 (IQR = 1-8) ova per HPF (Figures 14-16). We found a variety of tissue 
reactions surrounding S. haematobium ova, ranging from marked periovular granulation 
tissue to fibrosis. Genital mucosal tissue surrounding S. haematobium ova had a higher 
density of established blood vessels (vWF) compared to non-endemic healthy controls (p = 
0.017). There was no significant difference in the density of capillary buds between women 
with cervicovaginal S. haematobium infection and non-endemic or endemic negative 
controls (p = 0.44 and p = 0.95, respectively). However, immunostain to CD31 identified 
significantly more granulation tissue surrounding viable compared to calcified ova (p = 
0.032), and a tendency to increased density of capillary buds in tissue surrounding viable 
ova compared to healthy cervical mucosa (p = 0.052). 
 
Conclusion. Female genital mucosa with S. haematobium ova was significantly more 
vascularised compared to the density of established blood vessels in healthy cervical tissue. 
These findings might add to the understanding of the pathophysiological mechanisms in 
female genital schistosomiasis and of the postulated association with HIV infection. 
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Paper II 
HIV target cells in Schistosoma haematobium-infected female genital mucosa 
Jourdan PM, Holmen SD, Gundersen SG, Roald B, Kjetland EF. 
Am J Trop Med Hyg. 2011 85(6):1060–1064 
 
Background. S. haematobium frequently causes genital lesions in women and, similar to 
sexually transmitted infections, might increase the risk of HIV transmission. The aim of this 
study was to quantify the HIV target cells in schistosome infected female genital mucosa. 
 
Methods. The same cohort of cervicovaginal biopsies as in Paper I were immunostained for 
quantification of CD4+ T lymphocytes (CD3, CD8), macrophages (CD68) and dendritic 
Langerhans cells (S100 protein). 
 
Results. The density of periovular CD4+ T lymphocytes and macrophages were 
significantly higher in women with than in women without S. haematobium infected genital 
mucosa (p = 0.034 and p = 0.018, respectively). The highest density of macrophages was 
found in genital mucosa with viable ova and in non-endemic chronic cervicitis; between 
which there was no significant difference (p = 0.32). The highest densities of CD4+ T 
lymphocytes were found in cervicovaginal tissue with calcified S. haematobium ova; 
however, the median densities of CD4+ T lymphocytes were similar in tissue with viable 
ova (n = 2) and in tissue with calcified ova (n = 11, significance testing not performed due 
to low sample sizes). There was no increased density of Langerhans cells in S. haematobium 
infected female genital mucosa in this study (p = 0.25). There was no significant association 
between age and the density of CD4+ T lymphocytes or macrophages in the two groups (p = 
0.51 and p = 0.65, respectively). The median ages were similar in women with viable ova (n 
= 2) and in women with calcified ova (n = 11, significance testing not performed). 
 
Conclusion. The findings indicate that S. haematobium may significantly increase the 
density of HIV target cells (CD4+ T lymphocytes and macrophages) in the female genitals, 
possibly affecting HIV susceptibility in infected women. 
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Paper III 
Pathological mucosal blood vessels in active female genital schistosomiasis 
New aspects of a neglected tropical disease 
Jourdan PM, Randrianasolo BS, Feldmeier H, Chitsulo L, Ravoniarimbinina P, Roald B, 
Kjetland EF. 
Int J Gynecol Pathol. 2012, in press 
 
Background. S. haematobium infection is a prevalent, but neglected cause of 
gynaecological pathology in African women, and precise clinical descriptions are rarely 
available alongside histological sections. The aim of this study was to explore the 
histopathology of the mucosal vascular findings in female genital schistosomiasis. 
 
Methods. This case study presents previously unreported histopathological correlates of 
colposcopic images of abnormal mucosal blood vessels in two women with genital mucosal 
S. haematobium infection. 
 
Results. Colposcopic inspection showed schistosomal lesions surrounded by dilated, 
unevenly calibered and convoluted blood vessels in the cervicovaginal mucosa. In one case, 
histopathology revealed dilated and tortuous mucosal venules containing viable Schistosoma 
haematobium eggs surrounded by a thrombus (Figure 17). In another case, the 
histopathology showed a viable ovum penetrating the venule wall and the surrounding 
stroma was characterised by an intense host response with sprouting capillary buds (CD31) 
and endothelial cell activation. 
 
Conclusion. Thrombosis might in part explain the pathogenesis of the abnormal mucosal 
blood vessels visible in female genital schistosomiasis. The characteristic blood vessels 
could be an indication of a persistent tissue reaction to female genital S. haematobium ova. 
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Paper IV 
A simple method for precise quantification of immunohistochemically stained cells 
Jourdan PM, Holmen SD, Kjetland EF, Sandvik L, Roald B. 
Submitted 
 
Background. Computer-assisted image analysis may facilitate and even improve the 
quantitative analyses of immunostained tissue sections. However, access to simple, valid 
and low-cost models is limited. The aim of this study was to explore the validity and 
efficiency of a user-friendly and low-cost method developed in Papers I and II. 
 
Methods. Immunostained immune cells (CD3, CD8, CD68) and endothelial cell structures 
(vWF, CD31) in cervicovaginal tissue sections (n = 414) were quantified manually and by 
computer-assisted image analysis using ImageJ (National Institutes of Health, USA). 
 
Results. Automated counts corresponded very well with manual counts of CD3, CD8 and 
CD68 immunostained cells (intra-class correlation coefficients (ICCs) = 0.93-0.98), but less 
well with manual counts of vWF and CD31 immunostained endothelial cell structures (ICCs 
= 0.62-0.68). Significant ICCs between manual and computer-assisted counts of 
immunostained cells were achieved following inclusion of a limited number of images, and 
inclusion of more than ten images did not significantly improve the correlation coefficients. 
Computer-assisted image analysis would, according to this model, be faster and more valid 
and reliable than cell manual counting for analyses of approximately 50 images or more. 
 
Conclusion. The low-cost model for computer-assisted image analysis presented in this 
study is an efficient method for precise quantification of immunostained cells. The method 
should, however, be used with caution for more unevenly stained structures, such as 
endothelial cell structures. Further studies are warranted to explore other comprehensible 
and low-cost alternatives of computer-assisted image analysis. 
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Figure 14. Moderate tissue reaction to S. haematobium ova in the cervical mucosa. A 
moderate tissue reaction to S. haematobium ova was seen in most cases. Note the cluster of 
calcified ova, characteristic of S. haematobium infection. 
 
Figure 15. Granulation tissue and cellular infiltrate surrounding S. haematobium ova. 
In a few cases a heavy infiltrate of lymphocytes, plasma cells, eosinophils and macrophages 
dominated the periovular tissue reaction. 
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Figure 16. Fibrous tissue surrounding S. haematobium ova in the genital mucosa. 
Pronounced fibrosis with extracellular collagen fibres was seen in a few cases. Note the 
calcified S. haematobium ova and lack of cellular tissue response. 
 
Figure 17. Thrombus surrounding viable S. haematobium ova in the cervical mucosa. 
Note the dilated venule and presence of eosinophils. 
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6.0. Discussion 
This study demonstrates an increased density of blood vessels and HIV target cells in S. 
haematobium infected female genital mucosa. The clinically observed abnormal mucosal 
blood vessels could be an indication of a persistent tissue reaction to S. haematobium ova, 
and ova-associated thrombosis might in part contribute to the pathogenesis. Moreover, low-
cost computer software may provide valid and reliable analyses of tissue specimens. S. 
haematobium infection is a frequent cause of pathology in the female genital mucosa 
[90,93,94,180]. Studies indicate that female genital schistosomiasis could increase the risk 
of HIV transmission; however, the potential pathophysiological mechanisms for such an 
association have hitherto not been sufficiently explored [133,135,136].  
 
Periovular density of blood vessels 
This study found a significantly higher blood vessel density in S. haematobium infected 
genital mucosa compared with healthy cervical tissue from non-endemic controls. The 
denser vasculature consisted mainly of established blood vessels, whereas cases with viable 
ova contained granulation tissue rich in sprouting capillary buds significantly more often 
than cases with calcified ova. Similar changes were seen in positive controls. 
 
Some histopathological studies of female genital S. haematobium infection have described 
localised, increased vascularity in association with S. haematobium ova [86,87,119]. Studies 
of blood vessel proliferation in S. mansoni infection have suggested that soluble egg 
antigens (SEA) from viable ova induce neovascularisation by stimulating endothelial cell 
activation and proliferation [181,182]. Recent experimental studies indicate that blood 
vessel proliferation in S. mansoni not only accompanies hepatic fibrogenesis, but possibly 
also regression of fibrosis after treatment [183]. Wound healing is a variegated process 
depending on cause and extent of damage, but the formation of new blood vessels is not a 
commonly reported feature of the end stages [184,185]. 
 
Increased vascular density may impair the cervicovaginal tissue structure and lead to 
disruption of the genital mucosal barrier [143,186]. In clinical studies, cervical S. 
haematobium infection has been associated with bleeding tendency of the mucosal 
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membrane [93]. Further, endothelial cell surface proteoglycans have been reported to serve 
as HIV-1 receptors, and endothelial cells have been suggested to harbour HIV [187-190]. 
 
Periovular density of HIV target cells 
Human histopathological studies have demonstrated a range of periovular immune cells in 
standard HE stained tissue specimens of female genital S. haematobium infection 
[86,87,114,118,127]. The present study indicates that S. haematobium infected mucosa may 
contain a higher density of HIV target cells; CD4 + T lymphocytes and macrophages than in 
uninfected mucosa. On the one hand, this may create conditions conducive to HIV 
transmission to women. On the other hand, in S. haematobium and HIV co-infected women, 
the findings could imply an increased risk of HIV transmission from women [136,191]. 
 
Deposition of viable S. haematobium ova may recruit HIV target cells to the genital mucosa, 
similar to STIs [140,142,133,139,144,148,152,192]. In this study, an increased density of 
macrophages was found in association with viable S. haematobium ova. Studies indicate 
that eosinophils are among the main effector cells in the host response to the deposition of S. 
haematobium ova [62,65]. Some in vitro studies suggest that eosinophils may be susceptible 
to HIV infection [193-197], however this could not be assessed in our study due to the 
limited sample size. 
 
A moderate tissue reaction against S. haematobium has been seen in several 
histopathological studies [89,117,119,123,124,126,136,144,191]. The increased density of 
CD4+ T lymphocytes surrounding calcified ova in the present study suggests that chronic S. 
haematobium infection may sustain a long-lasting immune reaction in the tissue. 
Furthermore, the CD4+ T lymphocytes were associated with CD4+ cell apoptosis, 
indicating a persistent immune activation in the tissue [70]. Clinical data indicate that S. 
haematobium infection may cause chronic damage to the genital mucosa [93,96,198]. 
Moreover, the findings are in line with one study of S. haematobium infected mice, in which 
calcifying S. haematobium ova were capable of sustaining a persistent granulomatous 
reaction in the tissue [50]. 
 
We did not identify any association between the density of epithelial Langerhans cells and S. 
haematobium ova in the stroma. Recently, a study indicated that the function of dendritic 
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cells might be impaired in human S. haematobium infection [199]. Results from 
experimental studies indicate that S. mansoni infection activates dendritic cells by a 
modulated rather than a conventional pathway [200]. It was not possible to explore dendritic 
cell function or activation, or alternative dendritic cell markers in these tissue specimens due 
to formalin fixation and the limited biopsy sizes. 
 
A recent experimental study on rhesus monkeys found an increased mucosal susceptibility 
to de novo HIV infection in acute S. mansoni infection [201]. Taken together, this suggests 
that both acute and chronic schistosomiasis could stimulate immunological tissue responses 
in the female genital mucosa facilitating HIV transmission. The findings might add to the 
understanding of potential mechanisms for the epidemiologically observed increased odds 
of HIV infection in two S. haematobium endemic areas of Africa [135,191,202]. 
 
Clinicopathological correlates 
Gynaecological examinations of S. haematobium infected women may reveal dilated, 
tortuous and unevenly calibered blood vessels in the cervicovaginal mucosa [93]. These 
abnormal blood vessels are poorly described in pathological specimens. Post mortem and 
experimental studies of S. mansoni and S. haematobium infections suggest that abnormal, 
dilated blood vessels in schistosomiasis may be caused by the parasite worms or ova 
themselves, or by perivascular ova-induced granulomas and oedema [84,203-205]. In one of 
the study cases with largely dilated venules we demonstrated viable S. haematobium ova 
surrounded by a thrombus. The clinically observed abnormal mucosal blood vessels might 
be a result of endothelial damage, abnormal blood flow or thrombosis associated with ova 
deposition [84,203-206]. The clinical implications of these findings need to be further 
explored. 
 
Computer-assisted image analyses 
This study describes an efficient method for precise quantification of immunostained cells 
using low-cost software for computer-assisted image analysis. The method should, however, 
be used with caution for more unevenly stained structures such as endothelial cell structures. 
Our results correspond with a number of reports which suggest that computer-assisted 
quantitative analyses may be a valid and reliable way to quantify immunohistochemically 
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stained structures [166,169-172]. To our knowledge, this is one of few studies to have 
validated a simple and user-friendly model for computer-assisted image analyses of 
immunostained tissue. 
 
The method described in this study was run on a highly endemic, but neglected disease in 
Africa and would be particularly useful for pathologists with access to large series of tissue 
samples but with limited resources for addressing important research issues. Further studies 
are warranted to confirm the findings and to explore other comprehensible and low-cost 
alternatives for computer-assisted image analysis. 
 
Study limitations  
The sample size of the Malawian population is small and the data are not normally 
distributed. Age could therefore not be corrected for in regression analyses. Age was not 
significantly associated with the density of established blood vessels, CD4+ T lymphocytes 
or macrophages when tested with non-parametric tests. A small sample size makes the 
findings prone to type 1 and type 2 errors. This complicates the interpretation of the results, 
especially those related to viable ova, and particularly when findings are non-significant. 
 
The endemic biopsies originated from a study in rural Malawi and were 14 years old at the 
time of analyses, whereas most of the control biopsies were 10 to 20 years old. We cannot 
preclude that the process of fixation and duration of storage might have impaired the quality 
of antigen detection [207,208]. Furthermore, variations in the cervicovaginal tissue reactions 
between endemic and non-endemic populations may have affected the results [209]. 
However, the findings indicate that computer-assisted immunohistochemical quantification 
method may be valid for use on archival biopsies. 
 
Although the tissue areas selected for analysis were considered representative for the 
respective biopsies, only a limited area of the entire biopsy was analysed. Recently, one 
study demonstrated that the analysis of small biopsies may be comparable to that of larger 
specimens; however, the small area selections may have affected the representativity of our 
data [210]. Furthermore, analyses were performed by two investigators, and, although a 
second senior pathologist was consulted when necessary, the interpretations may have 
differed from that of other pathologists. Although initially blinded for the immunostains, the 
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investigators might have been influenced by the tissue reactions apparent in the HE-stained 
sections in the selection process of the regions of interest. 
 
In presumed negative cases, schistosome ova might have been located just outside the 
studied tissue sections, possibly affecting the histopathological results. Moreover, 
cervicovaginal biopsy procedures are cumbersome and the identification of pathology is 
dependent on adequate optical magnification and precisely sampled biopsies [93]. There 
was no true schistosomiasis negative endemic control group, as is the case for most studies 
on schistosomiasis [86,89,114,117-119,126], and the observed differences between cases 
and controls may therefore have been underestimated. 
 
The density of CD4+ T lymphocytes was estimated by subtracting the number of CD8+ 
cells from the number of CD3+ cells on two consecutive 3.5 m thick sections. Although 
the thickness of the sections were less than half the average diameter of a lymphocyte, the 
reported CD4+ cell density may to some extent have differed from its true value [178]. Our 
calculations of CD4+ T lymphocytes might have been slightly underestimated since 
antibodies to CD8 also recognise CD8 antigen on  T cells and natural killer cells (Dako). 
 
We were not able to apply computer-assisted image analyses on endothelial cell structures 
in this sample due to inconsistent immunostaining. Previous studies indicate that CD31 and 
vWF may show heterogeneous immunostaining [211-214]. One study found increased 
endothelial cell activation and vWF expression in HIV infected individuals [215]. Moreover, 
endothelial properties may be affected by the menstrual cycle [216]; however, this could not 
be assessed in this study due to a limited sample size. 
 
The HIV prevalence in Malawi is estimated to have been approximately 10% of the 
population at the time of sampling (1994) [217]. Infection with HIV may have affected the 
genital mucosal levels of CD4+ T lymphocytes [218]. HIV diagnosis was not a part of the 
original project and could therefore not be performed. Moreover, STIs may affect the 
pathogenesis in S. haematobium infected genital mucosa [93]. Apart from 
histopathologically apparent HPV infection, STIs could not be corrected for in the original 
study. Other factors that could have affected the immunological tissue processes, such as 
microtrauma and menstrual cycle, could not be adequately corrected for in this study [219]. 
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Pathogenesis in female genital S. haematobium infection 
In line with previous reports, this study found a variety of tissue reactions surrounding S. 
haematobium ova in the genital mucosa ranging from marked granulation tissue with potent 
eosinophils surrounding viable ova, to waning inflammation, calcified ova and fibrosis 
[86,87,89,114,117-119,123,124,126,127]. Fibrosis has by some been regarded as the end-
stage pathology in schistosome infected tissue [31]. In our study, there was an association 
between calcified ova and HIV target cells, whereas we found no significant association 
between calcified ova and fibrosis. The latter must be interpreted with caution as biopsies 
were directed at clinical pathology, and as the small sample size may lead to type 2 errors. 
 
The pathogenesis of female genital S. haematobium infection is still not fully understood. 
Prospective studies of human infection have not been performed and the sequence of 
pathological processes has not been adequately explored [220]. A clinicopathological study 
of S. haematobium-infected chimpanzees suggested that pathology in S. haematobium 
infection develops through polypoid patches to fibrous patches and sandy patches in the 
urinary and gastrointestinal tract [29]. A number of terms have been used to describe the 
various disease stages observed in human autopsy and surgical specimen studies; such as 
‘exudative’, ‘productive’ and ‘sclero-cicatricial’ stages [87] and ‘active’ and ‘inactive’ 
stages of disease [23,27,28,30,118]. 
 
Our findings suggest that any tissue reaction to S. haematobium ova, viable or calcified, 
should be regarded as schistosomal disease. Thus, we believe that terms such as ‘active’ and 
‘inactive’ do not adequately represent the potential clinical implications for the patient. In 
spite of the apparent lack of tissue reaction in some cases of female genital mucosal S. 
haematobium infection, our findings suggest that the histopathological changes could affect 
HIV susceptibility and morbidity in co-endemic areas [89,117,119,123,124,126,136,191]. 
 
The immunological host response to schistosome infection is complex and may be affected 
by a number of factors, including in utero sensitisation, the site of ova deposition, the 
frequency and degree of exposure, the duration and intensity of infection, and host factors, 
including genetic predisposition, nutrition, anti-schistosomal treatment and co-infections 
with other infectious agents [19,44-49]. Some studies have demonstrated increased urinary S. 
haematobium ova excretion in young children; a peak in teenagers and young adults and a 
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fall in older age groups; suggesting that the respective pathological processes may be age-
dependent [27,28,221-224]. However, others have reported a constant presence of S. 
haematobium-associated lesions across different adult age groups [93,94]. Although urinary 
ova excretion may decrease following anti-schistosomal treatment, S. haematobium induced 
urinary or genital mucosal lesions may remain refractory to such treatment [225-229]. 
 
Although a disputed matter, epidemiological and clinical data suggest that individuals in 
endemic areas may acquire immunological resistance to re-infection with S. haematobium 
[47,48,230-232]. Cheever et al suggested that “the pathologic effect of a given number of 
eggs per gram tissue varies greatly with the degree of host reaction to the eggs” [33]. The 
systemic immunological status may affect the local tissue reaction, and we hypothesise that 
the various tissue reactions to S. haematobium ova depend on the current immune status of 
the infected individual and the respective stage of immune adaptation to S. haematobium 
ova (Table 6 and Figure 18) [42]. The initially viable ova may thus be destroyed by 
macrophages and eosinophils (acute reaction), remain and calcify in the tissue, or possibly 
pass through and out of the tissue (chronic reaction). We would argue that the 
histopathological reactions to S. haematobium ova are pivotal in understanding the clinical 
implications of infection for the individual patient and the appropriate timing of treatment. 
 
 First infections prior to 
immune modulation 
Re-infections and gradual 
immune modulation 
Main immune cells 
involved 
Macrophages 
Eosinophils 
Lymphocytes 
Clinical manifestations Polypoid patches, 
rubbery nodules 
Abnormal mucosal blood 
vessels and contact bleeding 
Sandy patches 
Fibrous patches? 
Abnormal mucosal blood 
vessels and contact bleeding 
Reversibility? Possible Chronic changes probable 
Table 6. The suggested clinicopathological reactions to S. haematobium ova in the 
female genital mucosa. 
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Figure 18. A model for immunopathogenesis in S. haematobium female genital tissue. 
Immune adaption to S. haematobium infection might result in various histopathological 
reactions, depending on a number of factors including age, number of re-infections, anti-
schistosomal treatment and the individual genetic profile. Effector cells (black) such as 
macrophages and eosinophils, and chronic immune cells (white) such as lymphocytes may 
influence the clinical implications and susceptibility to HIV infection. Established blood 
vessels (far right) may be found in association with calcified S. haematobium ova. 
 
Male genital schistosomiasis and HIV susceptibility 
Male genital schistosomiasis is a highly neglected tropical disease and is poorly understood 
[126,233]. S. haematobium infection may cause lesions in all parts of the male genital tract, 
and may have a role in HIV transmission in co-endemic areas [84,126,191,234]. Genital 
ulcer disease may put men at high risk of HIV infection [235], and further understanding of 
the possible implications of male genital schistosomiasis is urgently needed. 
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7.0. Conclusions and perspectives for future research 
In conclusion, this study indicates that acute and chronic S. haematobium infection of the 
female genital mucosa might facilitate HIV transmission. Increased vascularity and density 
of CD4+ T lymphocytes surrounding calcified ova suggest that S. haematobium infection 
could create a long-lasting HIV susceptibility in chronically infected women. Characteristic, 
abnormal mucosal blood vessels might be a sign of persistent tissue reactions to ova. 
Histopathological and clinicopathological studies are needed to validate the findings and to 
further understand the pathogenetic mechanisms in female genital S. haematobium infection. 
 
Biopsy studies, including autopsy digestion and analyses of surgical specimens, should be 
performed in order to further explore the pathophysiological mechanisms in female genital S. 
haematobium infection. A better understanding of genital schistosomal disease staging and 
identification is warranted. In order to make recommendations regarding treatment, the 
effect of patient age and duration of infection should be explored. Furthermore, features 
associated with HIV susceptibility and infection should be explored, such as the role of 
immunological factors; immune activation, HIV co-receptors and Th17 cells, and the barrier 
function of the genital mucosal membrane. 
 
Clinicians working in S. haematobium and HIV co-endemic areas need to be aware of the 
clinical implications of female genital schistosomiasis in order to give appropriate advice 
and treatment. Present mass treatment campaigns in schistosomiasis endemic areas should 
be followed by targeted clinical investigations of sexually active females to explore whether 
the clinical findings could be used to monitor the effect of intervention. 
 
Finally, appropriate studies of male genital schistosomiasis, as well as studies of genital 
schistosomiasis due to S. mansoni, should be included in the targeted efforts to explore the 
possible HIV susceptibility in schistosomiasis endemic areas. 
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Abstract
Background: Close to 800 million people in the world are at risk of schistosomiasis, 85 per cent of whom live in Africa.
Recent studies have indicated that female genital schistosomiasis might increase the risk of human immunodeficiency virus
(HIV) infection. The aim of this study is to quantify and analyse the characteristics of the vasculature surrounding
Schistosoma haematobium ova in the female genital mucosa.
Methodology/Principal Findings: Cervicovaginal biopsies with S. haematobium ova (n = 20) and control biopsies (n = 69)
were stained with immunohistochemical blood vessel markers CD31 and von Willebrand Factor (vWF), which stain
endothelial cells in capillary buds and established blood vessels respectively. Haematoxylin and eosin (HE) were applied for
histopathological assessment. The tissue surrounding S. haematobium ova had a higher density of established blood vessels
stained by vWF compared to healthy controls (p= 0.017). Immunostain to CD31 identified significantly more granulation
tissue surrounding viable compared to calcified ova (p= 0.032), and a tendency to neovascularisation in the tissue
surrounding viable ova compared to healthy cervical mucosa (p= 0.052).
Conclusions/Significance: In this study female genital mucosa with S. haematobium ova was significantly more vascularised
compared to healthy cervical tissue. Viable parasite ova were associated with granulation tissue rich in sprouting blood
vessels. Although the findings of blood vessel proliferation in this study may be a step to better understand the implications
of S. haematobium infection, further studies are needed to explore the biological, clinical and epidemiological features of
female genital schistosomiasis and its possible influence on HIV susceptibility.
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Introduction
Schistosomiasis is the most important parasite infection in the
world after malaria [1]. Of the estimated 780 million people
exposed to this fresh water parasite, 85 per cent live in Africa.
Schistosoma haematobium and human immunodeficiency virus (HIV)
are co-endemic in large parts of this area [2,3]. In a recent cross-
sectional study from Zimbabwe a near 3-fold increased odds for
HIV infection was found in women with genital schistosomiasis
[4].
The lower female reproductive tract is a major entry site in HIV
transmission, and is also a common site for S. haematobium
oviposition [5–7]. The S. haematobium infected cervix appears
inflamed with abnormal mucosal blood vessels, contact bleeding
and pathognomonic lesions named sandy patches [7–9]. It has
been suggested that products from schistosome ova (S. mansoni)
may induce endothelial cell proliferation and activation [10,11].
Similar to sexually transmitted infections, it has been postulated
that female genital schistosomiasis may provide mucosal points of
entry for HIV [12,13].
The aim of this study is to combine immunohistochemical
protein detection of endothelial cells with histopathological
evaluation to quantify and analyse the characteristics of the blood
vessels surrounding S. haematobium ova in biopsies of the lower
female genital tract.
Methods
Ethics statement
Permissions for the histopathological and immunohistochemical
investigations of anonymised archival Malawian and Norwegian
biopsies, without additional consent from the study subjects, were
granted by the National Health Science and Research Committee
of Malawi (2009/NHSRC #620) and the Norwegian Regional
Ethics Committee (2009/1250a). The permissions were based on
the fact that the proposed analyses did not require identifiable
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information or history, have any direct relevance to the physical,
mental or social well-being, or have any direct diagnostic or
therapeutic implications for the study women.
The majority of the Malawian women who volunteered in the
1994 study were illiterate [8]. Study information was provided in
Yao and Chichewa (the local languages) and free informed oral
consent was obtained. Following consent, all women who had
urinary schistosomiasis were offered gynaecological examination.
Consent was reascertained orally by the physician before each step
of sampling and investigations. Treatment and follow-up for
sexually transmitted infections, cancers and other complaints were
done in collaboration with the physicians in Mangochi District
Hospital [8]. The women were not asked for HIV testing. All
women, including those who declined further investigations, were
offered treatment with praziquantel. All non-endemic controls
were followed up by the referring clinician in Norway.
Study subjects
As described previously [8], biopsies from the cervix and/or
vagina were sampled from 61 women with urogenital S.
haematobium infection in Mangochi District Hospital in Malawi in
1994. In short, sexually active women between 15 and 49 years of
age present in the out-patient department, irrespective of whether
they were patients or next of kin, were invited to submit urine
samples. Women with S. haematobium ova in the urine were invited
for further interviews and gynaecological examinations. Samples
including biopsies were taken from observed lesions or at random
if no lesions were present. Women without urinary schistosomiasis
were excluded.
An overview of the study groups is given in Figure 1. The cases
with S. haematobium ova in genital tissue included 17 cervical and
three vaginal biopsies. The histopathological changes and ova
viability were similar in the cervical and vaginal biopsies, and the
biopsies were therefore analysed together. Malawian women with
urinary schistosomiasis who were found not to have S. haematobium
ova in the biopsy specimen served as endemic negative controls.
Non-endemic Norwegian control biopsies were selected by
searching the database from 1998 for key word combinations of
the anatomical site ‘cervix uteri’ and the morphological diagnoses
‘cervicitis’ and ‘normal morphology’. Women included in the
negative non-endemic control group had histologically normal
uterine ectocervices with intact tissue architecture. Excluded were
endocervical biopsies and biopsies showing signs of pathology, i.e.
more than 10 inflammatory cells per high-power field, non-specific
vessel proliferation, epithelial hyperplasia, polyps, cysts, atypical or
dysplastic changes, or signs of human papilloma virus (HPV)
infection (i.e. clustered koilocytosis and dyskeratosis).
Women included in the positive non-endemic control group had
chronic non-specific cervicitis; i.e. biopsies with a distinct,
generalised infiltrate dominated by lymphocytes and/or plasma
cells. Excluded were endocervical biopsies with more than 20
granulocytes or 5 eosinophils per high-power field and specimens
with signs of HPV infection, erosion, ulcerations, granulation
tissue or extra-vascular erythrocytes.
Immunohistochemistry and histopathology
The biopsies were fixed in formalin, routinely processed,
embedded in paraffin, sectioned and stained. Findings from the
histological examination of haematoxylin and eosin (HE)-stained
sections have been published previously [14].
For the analyses in this study, 3.5 mm thick serial sections of the
included specimens were cut and placed on SuperFrost slides
(Menzel-Gla¨ser, Braunschweig, Germany) for HE-stain and on
SuperFrost Plus slides (Menzel-Gla¨ser) for immunohistochemical
stains. The immunohistochemical stains were performed using
Benchmark XT, Antibody diluent (251-018) and Detection Kit
Ventana ultraView Universal DAB (760-500) (Ventana Medical
Systems, Inc., Tucson, Arizona, USA), an automated immuno-
stain system based on the ABC avidin-biotin-peroxidase method,
including negative and positive controls. For identification of
blood vessels, two endothelial cell markers were used; mouse
monoclonal antibody CD31 (clone JC70A, Dako Denmark AS,
Glostrup, Denmark) and rabbit polyclonal antibody von Will-
ebrand Factor (vWF) (Ventana). All slides were examined
microscopically for immunohistochemical antigen detection com-
bined with histological identification.
Microscopy and image analysis
The sections were examined using a Nikon Eclipse 80i
microscope and photographed at 406 objective magnification,
obtaining 1600 by 1200 pixels colour images using a SPOT Insight
2 Megapixel Firewire Color 3-shot digital camera attached to the
microscope and a Hewlett-Packard Compaq stationary computer.
The morphological and immunohistochemical analyses were
performed in a standardised manner. First, the HE-stained
sections were evaluated. Ova were defined as ‘viable’ if miracidia
with eosinophilic glands or germinal cells were identified [15],
whereas ova containing dark purple stain identified histologically
as calcification were defined as ‘calcified’. The histopathological
tissue reaction was defined as ‘granulation tissue’ if dominated by
neovascularisation with activation of endothelial cells and by
immature fibroblasts. The tissue reaction was defined as ‘fibrosis’ if
dominated by collagen rich stroma with scant mature fibroblasts.
A high-power field (406 objective magnification) of each HE-
stained section containing S. haematobium ova was photographed
with the ovum or ova located centrally. The area of tissue
surrounding the ovum or ova in one such photograph was defined
as ‘periovular’. In the controls, one high-power field of a
subepithelial area was photographed, as this is the most common
location for oviposition [15,16]. This area was representative for
the pathologist’s overall diagnosis of the section. In order to
analyse the same area in the consecutive immunohistochemically
stained serial sections of each biopsy, the near-exact same areas,
Author Summary
Schistosomiasis is a fresh water parasite infection that
affects millions of people, especially in Africa. Recent
knowledge about the genital manifestations of schistoso-
miasis; especially its possible association with human
immunodeficiency virus (HIV) infection, has led to
increased focus on this neglected tropical disease. Millions
of women remain undiagnosed for genital schistosomiasis,
and may suffer from abnormal mucosal blood vessels,
contact bleeding and lesions named sandy patches. This
study analyses a unique selection of female genital
biopsies containing parasite eggs. Protein detection and
standard histopathological assessment are combined to
quantify and study the characteristics of the mucosal
blood vessels surrounding the eggs. Our results show that
the genital mucosa with parasite eggs is more vascularised
compared to healthy tissue, and that viable eggs tend to
be surrounded by proliferating blood vessels. These
findings have not yet been correlated directly to clinical
manifestations. Further studies are needed in order to
provide clinical advice on the risks and consequences of
mucosal lesions particular to female genital schistosomi-
asis.
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Figure 1. Overview of the study groups.
doi:10.1371/journal.pntd.0001170.g001
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identified by histological anatomical structures, were photo-
graphed. In areas where the morphology of the immunohisto-
chemically stained section differed from the HE-stained section,
the closest approximation was photographed. All selections were
controlled by an experienced pathologist (BR).
Immunostained blood vessels (by vWF and CD31) were counted
in accordance with pre-established criteria [17,18]. ‘Capillary
buds’ were defined as vessel structures without an identifiable
lumen or periendothelial structures, whereas all other stained
vessel structures were counted as ‘established blood vessels’. The
density of capillary buds and vessels were calculated per mm2. In
sections with more than 300 capillary buds per mm2, the numbers
were truncated to 300. Each photograph was counted manually
and one in ten randomly selected photographs were quality
controlled. Discrepancies were resolved by consensus, if necessary
after consulting a second senior pathologist. Finally, each
photograph was recounted.
Statistical analyses
The statistical analyses and sample size estimation were
performed with SPSS version 16.0 and PS Power and sample
size calculations version 2.1.31. Most variables were not normally
distributed and non-parametric tests were therefore used when
studying associations. Medians and interquartile ranges were used
to describe the results. The Mann-Whitney U and Kruskal-Wallis
H tests were applied where appropriate. For the calculation of
odds ratio (OR), it was necessary to tertilise the not normally
distributed variables. Spearman’s rank correlation coefficient was
used when studying associations between continuous variables.
Intra-observer variability was determined by calculating the intra-
class correlation coefficient (ICC) after log-transformation of the
data. A 5% significance level was used throughout.
Results
The median age of the Malawian patients was 23.5 years
(interquartile range (IQR)= 20.0–31.5), and the median age of the
Norwegian control patients was 44.0 years (IQR=30.5–55.5). In
the biopsies with S. haematobium ova, the median number of ova per
high-power field was 3 (IQR=1–8), of which 80 per cent were
calcified. Most ova were localised in the subepithelial tissue,
whereas only a few ova were found deeper in the stroma. Calcified
and viable ova were found together in the same biopsy in one
patient only. No schistosome worms were seen.
Figures 2 and 3A show the distributions of established blood
vessels and capillary buds respectively per mm2 genital tissue in the
four study groups. The periovular tissue contained significantly
Figure 2. Density of established blood vessels per mm2 in the four study groups. Established blood vessels stained with von Willebrand
Factor. FGS= cervicovaginal tissue with S. haematobium ova. aComparison of women with FGS and non-endemic women with normal cervical tissue.
doi:10.1371/journal.pntd.0001170.g002
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more established blood vessels compared with non-endemic
healthy cervices (p=0.017). However, ova viability was not
significantly associated with the density of established blood vessels
(p=0.40). There was no significant difference in the density of
established blood vessels between endemic biopsies with and
without S. haematobium ova (p=0.51).
As shown in Figure 3A, there were no significant differences in
the density of capillary buds between the Malawian cases and the
non-endemic or endemic negative controls (p=0.44 and p=0.95
respectively). However, there was a large variation in periovular
capillary bud density. As shown in Figure 3B, there was a tendency
towards a higher density of capillary buds surrounding viable ova
compared with non-endemic healthy cervical tissue (OR=13.0,
Confidence Interval (CI) = 1.0–172.9, p=0.052). Furthermore,
viable ova were more often found in granulation tissue compared
to calcified ova (p=0.032). There was no association between
calcified ova and fibrous tissue (p=0.53). The main histopatho-
logical periovular tissue reactions are shown in Figures S1 and S2.
In the endemic cases with cervicovaginal S. haematobium ova, age
was neither associated with the number of ova (p=0.45) nor the
viability status of the ova (p=0.50). There was no significant
difference in density of established blood vessels or capillary buds
between tissue with viable ova and non-endemic tissue with
chronic cervicitis (p=0.20 and p=0.053 respectively). All other
study groups had significantly lower densities of established blood
vessels and capillary buds than tissue with chronic cervicitis (data
not shown).
The intra-observer reliability of counting established blood
vessels and capillary buds were 0.93 (95% Confidence Interval
(CI) = 0.90–0.95, p,0.001) and 0.88 (95% CI= 0.82–0.91,
p,0.001), respectively.
Discussion
To our knowledge, this is the first study to analyse the quantity
and characteristics of the mucosal vasculature surrounding female
genital S. haematobium ova. Similar to non-specific chronic
cervicitis, the mucosa of the Malawian women diagnosed with
genital schistosomiasis was significantly more vascularised than
healthy cervical tissue of non-endemic controls. The denser
vasculature consisted of established blood vessels as opposed to
currently active neovascularisation. However, cases with viable
ova contained granulation tissue rich in sprouting blood vessels
significantly more often than cases with calcified ova.
Similar to previous reports of genital and urinary schistosomi-
asis, we found a variety of tissue reactions surrounding S.
haematobium ova; ranging from marked periovular granulation
tissue to fibrosis [14–16,19–25]. Although fibrosis is regarded as
the end-stage pathology in schistosome infected tissue [26], there
was no significant association between calcified ova and fibrosis in
our study.
This study has several limitations. Firstly, the sample size is
small and the findings are prone to type 1 and 2 errors. Secondly,
there may have been schistosome ova just outside the biopsy
borders in presumed negative cases, which might explain why
there was no significant difference in capillary density between
endemic cases and controls in this study. As in most schistosomiasis
studies, there was no true schistosomiasis negative endemic control
group [27]. The differences between women with and without
genital S. haematobium ova may therefore have been underestimat-
ed. Thirdly, the analyses may have been affected by the age of the
endemic biopsies, and by endothelial cell activation or vWF which
may be elevated in HIV positive individuals [28]. The HIV
prevalence has subsequently been estimated to be approximately
10 per cent of the population in 1994 [2], but individual HIV
diagnosis was not a part of the original project and could therefore
not be done. Lastly, although the specimens were evaluated several
times by two investigators who attempted to be objective, blinding
was not possible due to the presence of schistosome ova in the
tissue.
Previous studies on blood vessel proliferation and schistosomi-
asis have suggested that soluble egg antigens (SEA) from viable S.
mansoni ova induce neovascularisation by stimulating endothelial
cell activation and proliferation [10,11]. Recent experimental
studies indicate that blood vessel proliferation in S. mansoni not only
accompanies hepatic fibrogenesis, but possibly also regression of
fibrosis after treatment [29]. To our knowledge, there have been
no studies on S. haematobium and blood vessel proliferation.
Female genital schistosomiasis is associated with genital mucosal
bleeding tendency; a clinical finding that might support the
suggested HIV susceptibility in these women [30]. Endothelial cell
surface proteoglycans have been reported to serve as HIV-1
receptors, and endothelial cells have even been suggested to
harbour HIV [31–34]. Finally, an increase in microvessel density
may impair the original tissue structure and lead to easy disruption
of the genital mucosal barrier [35,36].
Women living in endemic areas are prone to high burdens of
infection and frequent reinfections with S. haematobium [37]. The
histopathological correlates of the clinical signs in female genital
schistosomiasis, e.g. abnormal blood vessel proliferation and
contact bleeding, have not yet been studied in detail [38]. It is
therefore not known which clinical manifestations may increase
the risk of reproductive tract morbidity or possibly HIV
acquisition. Hence it is not yet possible to give clinical advice
related to the risks and consequences of the typical lesions in
female genital schistosomiasis. In order to determine the
implications for the patients, further studies are needed to
correlate the clinical signs to morphological and immunohisto-
chemical findings.
In conclusion, this study shows that female genital mucosa
infected with S. haematobium is significantly more vascularised than
healthy cervical tissue. Viable schistosome ova are more often
surrounded by highly vascularised granulation tissue compared
with calcified ova. These results might contribute to improve the
understanding of the pathophysiological mechanisms in female
genital schistosomiasis and of the postulated association with HIV
infection. However, further studies are needed to validate these
findings, to study the immunological tissue reaction and to explore
the clinical correlates of the various histopathological manifesta-
tions in female genital schistosomiasis.
Supporting Information
Figure S1 Section of uterine cervix with calcified S.
haematobium ova. A. Histopathology Calcified schistosome
ova (white arrows) with periovular collagenised fibrous tissue (long,
Figure 3. Density of capillary buds. A. Density of capillary buds per mm2 in the four study groups. Capillary buds stained with CD31;
counts were truncated at 300 buds per mm2 for technical reasons. All non-endemic women with chronic cervicitis had capillary bud densities above
300 per mm2. FGS= cervicovaginal tissue with S. haematobium ova. aComparison of women with FGS and non-endemic women with normal cervical
tissue. B. Density of capillary buds per mm2 tissue with viable versus calcified ova.
doi:10.1371/journal.pntd.0001170.g003
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thin black arrows), scant mature fibroblasts (short, thin black
arrows) and established blood vessels (thick black arrow).
Haematoxylin and eosin (HE), 406 objective magnification. B.
Immunohistochemical detection of established mucosal
blood vessels Calcified schistosome ova (white arrows) with
periovular established blood vessels (black arrows). von Willebrand
Factor, 406 objective magnification.
(TIF)
Figure S2 Section of vagina with viable S. haematobium
ova. A. Histopathology Viable schistosome ova and shell
fragments (white arrows) surrounded by giant cells (long, thin
black arrows), granulation tissue, i.e. endothelial cell proliferation
and activation (E) and proliferation of immature fibroblasts (short,
thin black arrows), and inflammation with marked eosinophilia
(Eos). A tissue artifact (Art) traverses the lower half of the image.
Haematoxylin and eosin (HE), 406 objective magnification. B.
Immunohistochemical detection of mucosal blood vessel
budding Viable schistosome ova (white arrows) with abundant
periovular capillary blood vessel budding (black arrows). CD31,
406 objective magnification.
(TIF)
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